Sensing Intracellular Calcium: Stim1 And Orai1 Interactions At The Plasma Membrane by Calloway, Nathaniel
 Sensing Intracellular Calcium: STIM1 and Orai1 Interactions at the Plasma
Membrane
by Nathaniel Taylor Calloway 
This thesis/dissertation document has been electronically approved by the following individuals:
Baird,Barbara Ann (Chairperson)
Lin,Hening (Minor Member)
Cerione,Richard A (Minor Member)
  
 
SENSING INTRACELLULAR CALCIUM: STIM1 AND ORAI1 INTERACTIONS 
AT THE PLASMA MEMBRANE 
 
 
 
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
by 
Nathaniel Taylor Calloway 
August 2010
  
 
 
 
 
 
 
 
 
 
 
 
© 2010 Nathaniel Taylor Calloway
  
SENSING INTRACELLULAR CALCIUM: STIM1 AND ORAI1 INTERACTIONS 
AT THE PLASMA MEMBRANE 
 
Nathaniel Taylor Calloway, Ph. D.  
Cornell University 2010 
 
Store operated Ca2+ entry (SOCE) is a ubiquitous process in nonexcitable cells 
important for receptor signaling in hematopoietic and other cell types. The ER-
transmembrane Ca2+ sensor STIM1 and the plasma membrane Ca2+ channel Orai1 are 
the two essential protein components of SOCE. To further understand the mechanism 
by which STIM1 and Orai1 facilitate SOCE, I have characterized bimolecular and 
supramolecular electrostatic interactions involving these proteins, using an imaging-
based fluorescence resonance energy transfer (FRET) assay in RBL mast cells. Using 
this assay I initially identified positively-charged small molecule inhibitors of the 
STIM1-Orai1 interaction. Based on this information I hypothesized that these small 
molecules could be binding to and disrupting the C-terminal acidic coiled-coil of 
Orai1. Mutation of these acidic residues in Orai1 reduced its association with STIM1 
and caused constitutive clustering of Orai1 at the plasma membrane. I then identified a 
short polybasic sequence in the Ca2+ activating domain (CAD) of STIM1 that binds to 
this acidic region of Orai1. Mutation of this three amino acid basic sequence prevented 
association with wild type Orai1, but not with the Orai1 coiled-coil mutant. Despite 
the residual association between the Orai1 and STIM1 mutants, they cannot initiate 
SOCE, suggesting that the polybasic sequence in STIM1 and the acidic coiled-coil of 
Orai1 are important for Ca2+ gating. 
 Using multiple isoforms of type I phosphoinositide-5-kinase (PI5KI) and lipid 
 domain targeted inositol-5-phosphatases, I found that the STIM1-Orai1 interaction has 
a dual dependence on two pools of of phosphoinositide-(4,5)-bisphosphate (PIP2) in 
the plasma membrane that are distinguishable by their association with detergent 
resistant membranes and detergent solubilized membranes. These correspond to 
distinctive ordered lipid subregions and disordered lipid subregions in the membrane, 
respectively. Deletion of an N-terminal polyarginine sequence on Orai1 or a C-
terminal polylysine sequence on STIM1 interferes with these selective interactions 
with PIP2 pools localized to these subregions. Based on these findings, I propose a 
model in which Orai1 must translocate between functionally distinct membrane 
domains in a PIP2 dependent fashion, to engage STIM1 associated with PIP2 in 
ordered lipid subregions of the membrane. 
 
 iii 
BIOGRAPHICAL SKETCH 
 
Nathaniel Calloway was born in Durham, NC, to James and Marion Calloway, who 
fostered his love of science from a very early age. Even as a child, one of his favorite 
activities included “running experiments” in his parent’s bathroom or kitchen, to their 
great dismay. He perused his scientific interests at UNC-Chapel Hill, where he 
majored in chemistry. At Columbia university, while studying fluorescent dyes with 
Virginia Cornish, he met his fiancée Jennifer, and they decided together to relocate to 
Ithaca. At Cornell, Nathaniel worked for Barbara Baird and David Holowka studying 
the store operated Ca2+ response. Jennifer and Nathaniel are moving back to New York 
where they met to continue their careers. 
 iv 
 
 
 
 
 
 
 
 
 
 
 
 
This dissertation is dedicated to Jennifer Rokhsar, whose steadfast love and support 
has made this work possible 
 v 
 ACKNOWLEDGMENTS 
 
 
I would like to thank the National Institude of Health for funding this research. I 
would like to thank my various fellowship organizations for supporting me throughout 
my career at Cornell: the NIH chemistry-biology interface training grant program, the 
American Chemical Society Division of Medicinal Chemistry, and the American 
Heart Association Founder’s Affiliate predoctoral fellowship program. 
 
I would like to thank everyone in the Baird Lab, past and present, for creating a 
wonderful research environment. I would especially like to thank Norah Smith for her 
constant patience and willingness to help. I would like to thank Barbara Baird for 
being a great PI, and always supporting me, even if she wasn’t so crazy about some of 
my ideas. But perhaps most of all, I would like to thank Dave Holowka for being a 
wonderful mentor. I would not be half the scientist I am today without his guidance. 
 vi 
TABLE OF CONTENTS 
 
Biographical Sketch iii 
Dedication iv 
Acknowledgements v 
Table of Contents vi 
List of Figures ix 
List of Abreviations xi 
1. Introduction 1 
1.1. Mast cells mediate allergic reactions through the IgE receptor signaling 
pathway 1 
1.1.1. Mast cells express the high affinity IgE Receptor, FcεRI 2 
1.1.2. Multivalent antigen crosslinks the FcεRI receptor and initiates a 
tyrosine phosphorylation cascade 2 
1.1.3. PLCγ mobilizes secondary messengers necessary for 
degranulation 4 
1.2. Store Operated Calcium 5 
1.2.1. STIM1 and Orai1 are the essential molecular components of 
SOCE 6 
1.2.2. Mutational analysis of STIM1 and Orai1 8 
1.3. PIP2 as a signaling molecule 10 
1.3.1. Interactions with PIP2 at the plasma membrane are mediated by 
polybasic peptide sequences 12 
1.3.2. Pools of PIP2 12 
1.3.3. Role of PIP2 in regulating ion channels. 13 
1.4. Contributions from these studies 14 
References 16 
2. Molecular clustering of STIM1 with Orai1/CRACM1 at the plasma 
membrane depends dynamically on depletion of Ca2+ stores and on 
electrostatic interactions 23 
2.1. Abstract 23 
2.2. Introduction 24 
2.3. Experimental 26 
2.3.1. Cloning and Constructs. 26 
2.3.2. Cell Culture 27 
2.3.3. Live cell imaging 27 
2.3.4. Calcium Measurements 28 
2.3.5. FRET Imaging 28 
2.3.6. FRET calculations 29 
2.3.7. Online Supplemental Material 31 
2.4. Results 31 
2.4.1. STIM1 redistribution upon thapsigargin stimulation is 
accompanied by rearrangement of the ER in RBL mast cells.  31 
2.4.2. STIM1 and Orai1/CRACM1 co-redistribute to micron-sized 
dorsal membrane patches due to stimulation by thapsigargin. 34 
2.4.3. Antigen-stimulated co-redistribution of Orai1/CRACM1 and 
 vii 
STIM1is highly restricted compared to that stimulated by 
thapsigargin. 36 
2.4.4. FRET measurements reveal close interactions between STIM1-
mRFP and AcGFP-Orai1/CRACM1 that are sustained if stores are 
not refilled. 37 
2.4.5. D-Sphingosine and N,N-Dimethylsphingosine inhibit the 
association between STIM1 and Orai1. 41 
2.4.6. Charged amino acid residues in the C-terminus of 
Orai1/CRACM1 are important for its interaction with STIM1. 44 
2.4.7. Charged amino acid residues in the C-terminus of 
Orai1/CRACM1 are important for functional CRAC influx. 46 
2.5. Discussion 47 
References 57 
3. A basic sequence in STIM1 promotes Ca2+ influx by interaction with the C-
terminal acidic coiled-coil of Orai1 62 
3.1. Abstract 62 
3.2. Introduction 63 
3.3. Experimental 64 
3.3.1. Constructs and cloning 64 
3.3.2. Cell culture 64 
3.3.3. Confocal Microscopy 65 
3.3.4. Ca2+ Measurements 66 
3.3.5. FRET Measurements 66 
3.4. Results and Discussion 67 
3.5. Supporting Information Available 76 
References 77 
4. Stimulated Association of STIM1 and Orai1 is regulated by the balance 
between detergent resistant and detergent solublized pools of PIP2 79 
4.1. Abstract 79 
4.2. Introduction 80 
4.3. Experimental 82 
4.3.1. Constructs and cloning 82 
4.3.2. Cell Culture 82 
4.3.3. Confocal Microscopy and FRET 83 
4.3.4. Membrane Fractionation and Dot-Blots 84 
4.4. Results 85 
4.4.1. Cholesterol and phosphoinositides contribute to stimulated 
association of STIM1 and Orai1. 85 
4.4.2. P I5KIβ and PI5KIγ differentially modulate stimulated 
association of STIM1 with Orai1. 87 
4.4.3. Depletion of PIP2 from the DRM pool inhibits the thapsigargin-
stimulated association of STIM1 and Orai1. 90 
4.4.4. Polybasic sequences in STIM1 and Orai1 are determinants of 
the dependence of the STIM1-Orai1 interaction on PIP2 in 
membrane subregions. 92 
4.4.5. Segregation of Orai1 into into ordered lipid and disordered lipid 
subregions of the plasma membrane is dynamically controlled by 
 viii 
the distribution of PIP2 between these subregions. 96 
4.5. Discussion 98 
4.5.1. The thapsigargin mediated STIM1-Orai1 interaction is inhibited 
by PIP2 in the disordered lipid subregions of the membrane and 
enhanced by PIP2 in the ordered lipid subregions. 98 
4.5.2. The polybasic sequences on STIM1 and Orai1 confer the 
selectivity of DRM and DSM pools of PIP2 to the STIM1-Orai1 
interaction 99 
4.5.3. The thapsigargin mediated STIM1-Orai1 interaction requires 
the PIP2 mediated translocation of Orai from disordered lipid 
subregions to ordered lipid subregions of the membrane 102 
References 105 
5. Future Directions 108 
5.1. Further investigations of the molecular basis of the STIM1-Orai1 
interaction. 108 
5.2. The orchestrated movement of STIM1 and Orai1 at the plasma 
membrane. 109 
5.3. The biophysical basis of PIP2 phase selectivity. 111 
5.4. PIP2 selectivity in the antigen mediated STIM1-Orai1 interaction 112 
References 113 
A. The Antigen Mediated STIM1-Orai1 Interaction 115 
A.1. Enhancement of plasma membrane PIP2 with PI5K increases the 
antigen mediated STIM1-Orai1 interaction 115 
A.2. The antigen mediated STIM1-Orai1 interaction is sensitive to selective 
PIP2 depletion with targeted phosphatases 115 
A.3. Removal of the polybasic PIP2 directing sequences on STIM1 or Orai1 
removes the PIP2 pool selectivity for the antigen mediated interaction  116 
B. Supplement for  Chapter 2  121 
B.1. Experimental  121 
B.1.1. Primers Used for Cloning  121 
B.1.2. Immunocytochemical staining of STIM1-HA, Tubulin-eGFP.  124 
C. Supplement for Chapter 3  130 
D. Supplement for Chapter 4  131
 ix 
LIST OF FIGURES 
 
Figure 1.1: Early IgE Receptor Signaling. 3 
Figure 1.2: Domain Strucure of Orai1 and STIM1. 7 
Figure 1.3: Mechanism of STIM1 and Orai1-mediated SOCE. 9 
Figure 2.1: RBL mast cell expressing STIM1-mRFP (red) and ER-eGFP 
(green) exhibits stimulation-dependent changes in localization of 
these proteins. 32 
Figure 2.2: Timecourse of AcGFP-Orai1/CRACM1 and STIM1-mRFP 
formation of co-labeled plasma membrane domains following 
thapsigargin stimulation. 33 
Figure 2.3: Confocal images of AcGFP-Orai1/CRACM1 (green) and STIM1-
mRFP (red) in dorsal slices of RBL mast cells stimulated with 
antigen under different conditions affecting Ca2+ influx. 35 
Figure 2.4: FRET between AcGFP-Orai1/CRACM1 and STIM1-mRFP in 
plasma membrane of RBL mast cells 39 
Figure 2.5: Effects of sphingosine derivatives and mutation of the Orai1 C-
terminal coiled-coil on the STIM1-Orai1 interaction. 42 
Figure 2.6: Effects of sphingosine derivatives and mutation of the Orai1 C-
terminal coiled-coil on SOCE. 43 
Figure 2.7: Sphingosine and mutation of the Orai1 C-terminal coiled-coil 
induce punctae formation. 45 
Figure 3.1: Thapsigargin-mediated FRET. Thapsigargin (150 nM)-stimulated 
FRET between STIM1-mRFP and AcGFP-Orai1 constructs in 
RBL mast cells. 68 
Figure 3.2: Cellular distributions of Orai1 and STIM1. 71 
Figure 3.3:  Stimulated Ca2+ responses. 72 
Figure 3.4: Cartoon depicting basic features of proposed model for wild type 
and mutant STIM1 and Orai1 interactions. 75 
Figure 4.1: Thapsigargin stimulated SOCE and STIM1-Orai1 FRET following 
cholesterol depletion of PI4K inhibition. 86 
Figure 4.2: Differential effect of PI5KI isoform overexpression on thapsigargin 
stimulated interaction between  AcGFP-Orai1 and STIM1-mRFP 
and PIP2 concentrations. 89 
Figure 4.3: Differential effect of targeted PIP2 phosphatase overexpression on 
thapsigargin stimulated interaction between  AcGFP-Orai1 and 
STIM1-mRFP and PIP2 concentrations. 91 
Figure 4.4: The interaction between STIM1∆K and Orai1 lacks PIP2 pool 
selectivity. 93 
Figure 4.5: The interaction between STIM1 and Orai1∆R has altered PIP2 pool 
selectivity. 95 
Figure 4.6: Localization of Orai1 to DRM or DSM fractions depends on the 
presence of PIP2. 97 
Figure 4.7: Proposed scheme for the PIP2 dependednt association of STIM1 
and Orai1. 100 
Figure 5.1: Primary sequence analysis of Orai1 and STIM1. 110 
 x 
Figure A.1: Antigen mediated FRET between AcGFP-Orai1 and STIM1-mRFP 
in the presence of PI5KI isoforms. 117 
Figure A.2:  The antigen mediated STIM1-Orai1 interaction is selectively 
perturbed by targeted phosphatases. 118 
Figure A.3: The antigen mediated interaction between STIM1∆K and Orai1 
shows altered PIP2 selectivity. 120 
Figure A.4: The antigen mediated interaction between STIM1 and Orai1∆R 
shows altered PIP2 selectivity.   121 
Figure B.1: The integrated AcGFP fluorescence intensity for 18 cells used in 
Figure 2.6A to calculate FRET after thapsigargin stimulation. 125 
Figure B.2: α-Tubulin-eGFP, STIM1-HA with Alexa594-anti-HA, and 
overlay, demonstrating localization of epitope-tagged STIM1 with 
microtubules in fixed RBL cells 126 
Figure B.3: Timecourse thapsigargin-stimulated formation of AcGFP-
Orai1/CRACM1 and STIM1-mRFP co-labeled plasma monitored 
by TIRF. 127 
Figure B.4: Timecourse thapsigargin-stimulated formation of AcGFP-
Orai1/CRACM1 and STIM1-mRFP co-labeled plasma monitored 
by TIRF. 128 
Figure B.5: Equitorial Cross-sections 129 
Figure C.1: Population distributions of Ca2+ levels. 130 
Figure D.1: Inhibition of SOCE by cholesterol depletion and membrane 
depolarization. 131 
Figure D.2: Distribution of AcGFP-Orai1∆R before and after thapsigargin 
stimulation.   132
 xi 
  LIST OF ABBREVIATIONS 
 
AcGFP Aequorea coerulescens Green Fluorescent Protein 
Ag Antigen 
2-APB 2-aminoethoxydiphenylborane 
BSA  Bovine Serum Albumin 
BSS Buffered Salt Solution 
Ca2+ Calcium 
CAD CRAC Activating Domain 
CaM Calmodulin 
CRAC Ca2+ Release Activated Ca2+ 
CRACM1 Ca2+ Release Activated Ca2+ Mediator 1 (a.k.a. Orai1) 
COS7 Green monkey kidney epithelial cell 
CTB Cholera Toxin subunit B 
DAG Diacyl Glycerol 
DMEM Dulbecco’s Modified Eagle’s Medium 
DMS Dimethylsphingosine 
DNP-BSA Dinitrophenyl conjugated Bovine Serum Albumin 
DRM Detergent-Resistant Membrane 
DSM Detergent-Solublized Membrane 
eCFP Enhanced Cyan fluorescent Protein 
EGF Epidermal Growth Factor 
eGFP Enhanced GFP 
ENaC Epithelial Sodium Channel 
ER Endoplasmic Reticulum 
eYFP Enhanced Yellow fluorescent Protein 
FBS Fetal Bovine Serum 
FcεRI High affinity receptor for immunoglobulin E 
FRET Fluorescence Resonance Energy Transfer 
GAP-43 Growth Associated Protein 43 
Gd3+ Gadolinium 
GFP Green Fluorescent Protein 
HEK Human Embryonic Kidney cell 
ICRAC Ca
2+ Release Activated Ca2+ Current 
IgE Immunoglobulin E 
Inp54p Yeast phosphatidylinositiol-(4,5)-bisphosphate 5-phosphatase 
IP3 Inositol-(1,4,5)-trisphosphate 
IP3R Inositol-(1,4,5)-trisphosphate Receptor 
ITAM immunotyrosine activation motif 
L10 Lck membrane targeting sequence 
LAT Linker for Activation of T-cells 
MARCKS Myristoylated Alanine-Rich C-Kinase Substrate 
MβCD Methyl-β-cyclodextrin 
MEM Minimal Essential Medium 
mRFP Monomeric Red Fluorescent Protein 
NFAT Nuclear Factor of Activated T-cells 
 xii 
PDI Protein Disulfide Isomerase 
PI Phosphatidylinositol 
PI4P Phosphatidylinositol-4-phosphate 
PI5KI Type I phosphotidylinositol-4-phosphate 5-kinase 
PIP2 Phosphatidylinositol-(4,5)-bisphosphate 
PIPs Phosphatidylinositol phosphates 
PKC Protein Kinase C 
PLC Phospholipase C 
PM Plasma Membrane 
RBL Rat Basophilic Leukemia cell 
S15 c-Src membrane targeting sequence 
SAM Sterile α Motif 
STIM1 Stromal Interaction Molecule 1 
SERCA Sarcoplasmic-Endoplasmic Reticulum Ca2+ ATPase 
SOC Store Operated Ca2+ 
SOCE Store Operated Ca2+ Entry 
TCR T-Cell Receptor 
TIRF Total Internal Reflection Fluorescence 
TMS Trimethylsphingosine 
TRPC Canonical Transient Receptor Potential Channel 
 
 
 1 
CHAPTER 1 
INTRODUCTION 
 
1.1 Mast cells mediate allergic reactions through the IgE receptor signaling 
pathway 
 
Allergic disorders cause a spectrum of pathologies from rhinitis, asthma, and eczema 
to acute anaphylaxis. Despite the diversity of symptoms and severity, all allergic 
disorders are characterized by a hypersensitivity of the body’s immune system to an 
otherwise innocuous substance. This so called type I hypersensitivity is caused by 
generation of immunoglobulin IgE in response to exposure to an allergen, and the 
subsequent sensitization of the body’s immune system to this allergen via the binding 
of IgE to the membrane of immune cells. The primary cells associated with IgE 
mediated sensitization are basophils, primarily found in the circulatory system, and 
mast cells, found in peripheral tissues such as skin and mucosa. Because mast cells 
reside in tissues that are the primary sites of contact with foreign substances and 
therefore allergen exposure, they are considered the primary mediators of IgE 
mediated hypersensitivity. Both mast cells and basophils are characterized by a dense 
accumulation of allergic mediators into granules in the cytoplasm. Sensitized mast 
cells respond to exposure to allergen by releasing these allergic mediators such as 
histamine into the surrounding tissue in a process called degranulation, resulting in the 
characteristic symptoms associated with a particular allergic disorder. Because of both 
the widespread prevalence of allergic disorders and the severity of some cases, 
understanding the mechanism of IgE mediated mast cell degranulation is of significant 
importance. 
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1.1.1 Mast cells express the high affinity IgE Receptor, FcεRI 
 
Mast cells are derived from CD34+ progenitor cells. During an allergic response, mast 
cells become sensitized to a particular antigen via the binding of IgE to the high 
affinity IgE receptor, FcεRI. This receptor in mast cells is a heterotetramer consisting 
of an α, β, and two γ subunits (Figure 1.1A). The α subunit binds IgE (Hakimi 1990) 
and is responsible for the high affinity of this receptor (10-10 M-1), as opposed to so-
called low affinity IgE receptor found in other cell types (Gould 2008). The γ subunits 
form a disulfide linked dimer and are associated with initiation of downstream signal 
transduction. The pairing of an α and two γ subunits constitutes an active IgE receptor 
associated with antigen presentation in other hematopoietic cell types (Kinet 1999), 
but in mast cells, the presence of the β subunit to form a tetrameric complex is 
associated with increased surface expression and increased signal transduction 
(Hartman 2008, Lin 1996). Both the β and γ subunits contain tyrosine phosphorylation 
sites conserved across all immunoglobulin receptors termed immune tyrosine 
activation motifs (ITAMs). In the resting state, tyrosine phosphatases maintain the 
ITAMs in a dephosphorylated state. 
 
1.1.2 Multivalent antigen crosslinks the FcεRI receptor and initiates a tyrosine 
phosphorylation cascade 
 
The IgE receptor signaling cascade leading to degranulation occurs in sensitized mast 
cells after exposure to multivalent antigen. Antigens with multiple epitopes 
simultaneously bind multiple IgEs on the cell surface and aggregate the associated 
FcεRI receptors. This aggregation is associated with translocation of the complex into 
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Figure 1.1: Early IgE Receptor Signaling. Schematic diagram depicting the first 
stages in IgE receptor signaling. A) The high affinity IgE receptor, FcεRI, consists of 
one IgE binding α subunit, a β subunit, and two γ subunits. B) After multiple receptors 
are crosslinked by multivalent antigen, the membrane-bound tyrosine kinase, Lyn, 
phosphorylates the β and γ subunits of FcεRI. C) The phosphorylated receptor recruits 
the cytoplasmic tyrosine kinase Syk, which phosphorylates LAT. D) Phosphorylated 
LAT recruits PLCγ to the plasma membrane, which cleaves PIP2 to IP3 and DAG. 
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detergent resistant membrane (DRM) domains in the plasma membrane (Sheets 1999). 
The DRM domains, also called lipid rafts, are distinguishable regions of the plasma 
membrane with increased concentrations of cholesterol, sphingolipids and saturated 
acyl chain phospholipids. DRM domains are associated with decreased mobility of 
transmembrane proteins, while letting proteins anchored to the membrane by lipids 
diffuse more readily. After translocation of the FcεRI receptor complex into the DRM 
domain, the accessibility of deactivating transmembrane phosphatases is significantly 
reduced, whereas the acylated tyrosine kinase Lyn is fully active and free to engage 
the FcεRI complex (Young 2005) (Figure 1.1B). The differential mobility of these 
proteins results in a 5x increase in the specific activity of Lyn (Young 2003), and the 
phosphorylation of ITAM sites on FcεRI (Lin 1996, Sil 2007). The phosphorylated γ 
subunit recruits the cytosolic tyrosine kinase Syk to the plasma membrane, where it 
phosphorylates the Linker for Activation of T-cells (LAT) (Saito 2000) (Figure 1.1C). 
LAT is a plasma membrane-associated adaptor protein that recruits phospholipase Cγ 
(PLCγ) to the plasma membrane, where it is phosphorylated and activated by Syk. 
 
1.1.3 PLCγ mobilizes secondary messengers necessary for degranulation 
 
Activated PLCγ cleaves the headgroup of the phospholipid phosphatidylinositol 4,5,-
bisphosphate (PIP2) to produce the secondary messengers inositol 1,4,5-trisphosphate 
(IP3) and diacylglycerol (DAG) (Figure 1.1D). IP3 binds to IP3 receptor (IP3R) on the 
ER membrane, activating Ca2+ efflux from ER stores. This Ca2+ store depletion results 
in the influx of extracellular Ca2+ via a mechanism termed Store Operated Calcium 
Entry (SOCE). The rise in intracellular Ca2+ is necessary for a wide range of effects 
including granule exocytosis (James 2008), and translocation of the Nuclear Factor of 
Activated T-cells (NFAT) to the nucleus, where it enhances transcription of 
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inflammatory cytokines (Yusang 2007). The other cleavage product of PLCγ, DAG, 
activated protein kinase C (PKC) at the plasma membrane. The combination of a rise 
in intracellular Ca2+ and PKC activation at the plasma membrane is necessary and 
sufficient to cause granule exocytosis (Sagi-Eisenberg 1984). 
 
1.2 Store Operated Calcium Entry 
 
Historically, SOCE was first proposed as a mechanism to explain why the release of 
Ca2+ associated with IP3 generation was larger than the pool of Ca
2+ in stores governed 
by IP3R (Putney 1986). Depletion of stores using the sarcoplasmic/endoplasmic 
reticulum Ca2+ ATPase (SERCA) pump inhibitor, thapsigargin, similarly causes influx 
of extracellular Ca2+, bolstering the hypothesis that influx was primarily controlled by 
the state of the internal Ca2+ stores (Putney 1993). The electrophysiological 
identification of Ca2+ Release Activated Ca2+ current (ICRAC) was consistent with the 
presence of a store operated pool of Ca2+ (Hoth 1993). ICRAC is an inwardly rectifying 
Ca2+ current triggered by release of Ca2+ from the lumen of the ER. ICRAC is also 
characterized by its high sensitivity to inhibition by Gd3+ ions (Hoth 1993) and the 
pharmacological inhibitor 2-aminoethoxydiphenylborane (2-APB) (Ma 2000). 
As described above, SOCE is an essential step in the mast cell mediated 
allergic response. However, SOCE is the primary mode of intracellular Ca2+ 
modulation in all non-excitable cells, and is utilized in a wide range of physiological 
processes. There are several varieties of Severe Combined Immunodeficiency 
Syndrome (SCIDS) associated with defects in SOCE (Feske 2010), due to its central 
role in the signaling of all hematopoietic cell types. Proliferation of T-cells is a SOCE 
dependent process (Lewis 2001). SOCE is essential in platelets for the formation of 
pathological thrombi, (Varga-Szabo 2008, Braun 2009). Migration of both metastatic 
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breast cancer cells (Yang 2009) and PDGF stimulated smooth muscle cells (Bisaillon 
2010) is dependent on SOCE. Because of the wide range of clinical applications, the 
importance of understanding SOCE is not limited to the pursuit of understanding mast 
cell mediated signaling. 
 
1.2.1 STIM1 and Orai1 are the essential protein components of SOCE 
 
Two proteins are essential for SOCE: Stromal Interaction Molecule 1 (STIM1), an 
ER-transmembrane Ca2+ sensor (Liou 2005), and Orai1 (a.k.a. CRACM1), a tetraspan 
plasma membrane Ca2+ channel (Feske 2006) (Figure 1.2). The coexpression of 
STIM1 and Orai1 is sufficient to reconstitute SOCE in deficient cell types (Soboloff 
2006). STIM1 contains a luminal EF-hand domain that senses depletion of Ca2+ from 
the ER (Zhang 2005). Mutation of the EF-hand domain in STIM1 to prevent Ca2+ 
binding results in constitutive influx of Ca2+ ions. Release of Ca2+ from the EF-hand 
domain following store depletion triggers oligomerization of STIM1 through its 
luminal, juxtamembrane sterile-α motif (SAM) domain (Stathopulos 2006), and this 
oligomerization triggers the translocation of STIM1 to regions of the ER that come 
into close proximity to the plasma membrane (Luik 2008) (Figure 1.3). 
Oligomerization of STIM1 triggers translocation to ER-plasma membrane junctions 
via the clustering of its C-terminal polylysine domain (Park 2009). Clustering of these 
basic motifs due to STIM1 oligomerization provides the energetic driving force for 
interaction with acidic phospholipids at the plasma membrane. Orai1 coaggregates 
with STIM1 at these ER-plasma membrane junctions, which opens its Ca2+ selective 
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Figure 1.2: Domain Strucure of Orai1 and STIM1. Orai1 (top) is a plasma 
membrane  (PM) localized Ca2+ channel, with the ion selective pore formed by four α-
helical transmembrane domains (TM). Additionally, Orai1 contains a regulatory N-
terminus and a C-terminus consisting of an acidic coiled-coil domain. STIM1 (bottom) 
is an ER transmembrane protein with a Ca2+ sensing luminal EF-hand domain. 
Additionally, STIM1 contains a sterile alpha motif (SAM), the CRAC activating 
domain (CAD), serine/proline rich domain (S/P), and a polylysine sequence (K). 
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pore, resulting in the characteristic inwardly rectifying Ca2+ current associated with 
SOCE. Orai1 interacts with the CRAC activating domain (CAD) on STIM1 to elicit 
influx (Park 2009). The CAD domain consists of a series of coil-coils, and also 
appears to be important for the oligomerization of STIM1 (Covington 2010). Soluble 
CAD spontaneously oligomerizes and initiates SOCE. However, the coupling of the 
CAD domain to either the polylysine motif or to the ER transmembrane domain of 
STIM1 prevents the activation of SOCE in the absence of stimulated oligomerization. 
The precise molecular nature of the interaction between the STIM1 CAD domain and 
Orai1 and the gating of Ca2+ influx is still poorly understood. STIM1 has one 
mammalian homologue, STIM2, that is associated with maintenance of the basal 
cytoplasmic Ca2+ levels and has a low level of constitutive translocation to the plasma 
membrane (Brandman 2007). STIM1 and STIM2 coaggregate after Ca2+ store 
depletion via their respective SAM domains. Orai1 has two homologues, Orai2 and 
Orai3. Heteropentameric complexes formed between Orai1 and Orai3 are arachidonate 
regulated Ca2+ channels instead of SOC channels (Mingnen 2009). Orai2 function is 
poorly understood. The interactions between all STIM and Orai isoforms are governed 
by the same CAD dependent mechanism. 
 
1.2.2 Mutational analysis of STIM1 and Orai1 
 
Numerous studies have been performed to elucidate the molecular mechanism of 
SOCE activation. The first studies to identify STIM1 as the ER Ca2+ sensor mutated 
residues in the Ca2+ binding EF-hand domain of STIM1 to produce a mutant that 
constitutively activates SOCE and punctae formation (Zhang 2005). Structural 
mutations in the EF-hand and SAM domains reveal that binding of Ca2+ into the EF- 
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Figure 1.3: Mechanism of STIM1 and Orai1-mediated SOCE. A) Recruitment of 
PLCγ to the plasma membrane generates IP3 by cleaving PIP2. B) IP3 binds to IP3R in 
the ER membrane, releasing Ca2+ from the ER stores. C) Dissociation of Ca2+ from the 
EF-hand domain of STIM1 (red crecent) causes oligomerization mediated by the SAM 
domain of STIM1 (green). D) Oligomerization of STIM1 causes translocation to ER-
plasma membrane junctions. E) Orai1 clusters with the STIM1 CAD domain at ER-
plasma membrane junctions. F) Clustering of Orai1 initiates SOCE. 
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hand stabilizes the structure of both domains, and that in the Ca2+ unbound form, 
oligomerization is mediated by a poorly structured SAM domain (Staphopulos 2008). 
Mutations to remove the cytosolic coiled-coil domain of STIM1 impared its capacity 
to engage Orai1 and initiate SOCE (Baba 2006). However, the same study revealed 
that removal of the C-terminal polylysine motif of STIM1 did not impair its capacity 
to initiate Ca2+ influx. Mutations in this coiled-coil domain have been found to alter 
the selectivity of STIM1 for different Orai isoforms: STIM1 (L373S) cannot engage 
Orai1 or initiate SOCE without the simultaneous expression of Orai3 (Frischauf 
2009). 
Orai1 was initially identified as a dominant negative gene causing SCIDS. This 
gene encoded a mutant of Orai1 (R91W) that was dysfunctional in SOCE (Feske 
2006). Later, it was determined that this mutation caused an increase in the 
hydrophobicity of the N-terminus of Orai1, leading to impaired Ca2+ influx (Derler 
2009). Although Orai1 was known to be essential for SOCE, it was not definitively 
identified as the Ca2+ selective channel until mutations in the four transmembrane 
domains were demonstrated to alter the ion selectivity of the store operated response 
(Yeromin 2006). Muik, et al., demonstrated that the coiled-coil domain at the C-
terminus of Orai1 is important for SOCE and the interaction with STIM1, because 
mutations to disrupt or delete this domain resulted in reduced Ca2+ influx and lack of 
punctae formation (Muik 2008). Additionally, they demonstrated that the N-terminus 
of Orai1 is important for SOCE, but mutations in this region did not reduce the 
capacity of STIM1 to bind Orai1. 
 
1.3 PIP2 as a signaling molecule 
 
Phosphatidylinositol (PI) and its derivatives are phospholipid signaling molecules with 
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a diverse range of intracellular functions. The inositol head group can be multiply 
phosphorylated at the 3, 4, and 5 positions to yield different signaling molecules with 
different subcellular localizations. These phosphatidylinositol phosphates (PIPs) serve 
as biochemical markers for the recognition of different intracellular compartments. For 
instance, PI(4,5)P2 is primarily localized at the plasma membrane, whereas PI4P and 
PI3P are localized at the Golgi and at endosomes, respectively (De Matteis 2004). 
Other PIPs serve to send broad spectrum signals about the state of the cell. For 
instance PI(3,4,5)P3 is a signaling molecule associated with survival and 
differentiation (Cantley 2002) 
PI(4,5)P2 (or simply PIP2) is one of the earliest identified and most widely 
studied PIPs, although it constitutes only ~1% of the total phospholipids content in the 
cell (McLaughlin 2002). PIP2 is generated by the phosphorylation of PI(4)P at the 
plasma membrane by PI(4)P-5-kinase (PIP5K). PIP2 is the primary mediator of the 
interaction between the cytoskeleton and the plasma membrane, and has therefore 
been implicated as essential for cell adhesion (Ling 2002), membrane ruffling (Honda 
1999), and phagocytosis (Coppolino 2002). PIP2 promotes membrane remodeling by 
recruiting the Wiscott-Aldrich syndrome protein (WASP) to the plasma membrane, 
where it initiates actin polymerization (Janmey 2004). PIP2 also promotes integrin-
mediated interaction with the extracellular matrix by activation of focal adhesion 
kinase (Ling 2002) and the formation of clathrin-coated pits by recruitment of AP-2 
(Di Paolo 2006). The concentration of PIP2 at the plasma membrane is tightly 
controlled by PIP5K and other enzymes, because in addition to its role in membrane 
remodeling, PIP2 also serves as the substrate for phospholipase C (PLC) to generate 
IP3 and DAG by cleavage of the inositol headgroup. 
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1.3.1 Interactions with PIP2 at the plasma membrane are mediated by polybasic 
peptide sequences 
 
PIP2 contains a very high charge density with a net charge of -5 when fully 
deprotonated. This high negative charge density provides the driving force for the 
association PIP2 with polybasic peptides carrying a high positive charge density 
(McLaughlin 2005). Polybasic motifs are very common throughout the proteome. For 
instance, of the approximately 60 known small GTPases, 37 are functionally recruited 
to the plasma membrane via polybasic motifs (Heo 2006). Moreover, PIP2 is necessary 
for the function and trafficking of transmembrane proteins. T-cell receptor ζ (TCRζ), 
FcεRIγ, and epidermal growth factor (EGF) receptor all contain polybasic motifs 
important for their functionality (Sato 2006, Sigalov 2006). Based on their studies of 
the myristylated alanine-rich C-kinase substrate (MARCKS), McLaughlin and 
Aderem proposed that proteins use polybasic domains as a form of biochemical switch 
that senses a particular concentration of PIP2 at the plasma membrane (McLaughlin 
1995). Other studies have demonstrated that binding of Ca2+-calmodulin (CaM) to the 
polybasic peptides in MARCKS and EGF receptor can reverse this association with 
PIP2 (Arbuzova 1998, Sato 2006). 
 
1.3.2 Pools of PIP2 
 
PIPs are the biochemical markers that delineate different membrane pools inside the 
cell. However, there are multiple lines of evidence suggesting that there are multiple 
distinctive pools of PIP2 residing at the plasma membrane. Multiple functional pools 
of PIP2 were identified in erythrocytes as early as 1987 (King 1987), but the nature of 
these pools has remained elusive. Vasudevan, et al., found that PIP5Kβ and PIP5Kγ 
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generate two distinct functional pools of PIP2 at the plasma membrane associated with 
SOCE and IP3 production, respectively (Vasudevan 2009). 
Because PIPs are normally the biological markers for membrane pools, there 
must be a different mechanism of differentiating multiple pools of PIP2 in the plasma 
membrane. A distinct possibility is that PIP2 pools are differentiated based on their 
localization to ordered lipid domains commonly called rafts and disordered membrane 
domains. Caveolin was originally implicated in the transport of PIP2 into the raft 
fraction and the delineation of multiple PIP2 pools (Pike 1996), but PIP2 constitutively 
enters the raft membrane fraction as determined by sucrose gradient fractionation even 
in the absence of caveolin (Liu 1998). Besides simply concentrating at the plasma 
membrane, the polybasic effector domain of MARCKS and other polybasic small 
molecules have also been found to kinetically trap PIP2 into lateral clusters (Denizov 
1998, Wang 2002). The polybasic PIP2 binding protein GAP-43 is known to recruit 
PIP2 into the raft fraction (Tong 2007), and there are demonstrable differences in the 
biological function of PIP2 in the raft and non-raft domains: non-raft localized PIP2 
appears to be more important for cytoskeletal remodeling and migration (Johnson 
2008). There is also some evidence that signaling events leading to production of PIP2 
produce PIP2 with more heavily saturated acyl chains than PIP2 in the resting state in 
Arabidopsis (König 2007). 
 
1.3.3 Role of PIP2 in regulating ion channels. 
 
Besides its role in regulating the cytoskeleton, PIP2 is an important signaling molecule 
for the regulation of plasma membrane ion channels. PIP2 has a clearly defined role in 
the regulation of TRP channels, voltage gated Ca2+ channels, IP3R, ryanodine receptor 
(RyR), and Na+-Ca2+ exchangers (Hilgemann 2001, Voets 2007). Moreover, the 
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signaling products of PIP2, IP3 and DAG, have been implicated in the regulation of 
intracellular ions as well: IP3 is the master regulator of intracellular Ca
2+ by releasing 
Ca2+ from intracellular stores via IP3R, and DAG has been implicated in the gating of 
certain TRP channels (Hardie 2002). The same regulatory C-terminal coiled-coil on 
certain TRP channels that recognizes the presence of DAG also binds to and is 
activated by PIP2 in other TRP channel isoforms. The TRP isoforms that bind PIP2 
contain a polybasic motif on this coiled-coil, whereas those that are gated by DAG 
contain a polyacidic motif.  Mechanisms have been proposed whereby TRP channel 
regulation by DAG is mediated by the avoidance of unfavorable charge-charge 
interactions between the acid coiled-coil and PIP2, whereas DAG can occupy the 
binding site without forcing these interactions. Similarly, the epithelial Na+ channel 
(ENaC) is activated by PIP2, and this activation is mediated by a juxtamembrane 
polybasic motif (Pochynyuk 2007a, Pochynyuk 2007b). Similar to other PIP2 binding 
proteins, the polybasic PIP2 binding motifs also serve as substrates for Ca
2+-
calmodulin binding (Voets 2007), resulting in dual modulation by PIP2 and Ca
2+. 
 
1.4 Contributions from these studies 
 
Despite the abundance of biochemical evidence indicating that the proteins STIM1 
and Orai1 are necessary for SOCE and important for mast cell signaling, the precise 
molecular interactions between these proteins that facilitate SOCE are still poorly 
understood. In this dissertation, I present a series of studies to examine the molecular 
basis of the STIM1-Orai1 interaction. In Chapter 2, I describe a FRET-based assay for 
the interaction between fluorescently labeled STIM1 and Orai1. In this study, we find 
that following the antigen mediated stimulation of SOCE, there is remarkable little 
interaction between STIM1 and Orai1, suggesting that Ca2+ stores are quickly refilled 
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under these conditions. Also using this FRET assay, we determine that electrostatics at 
the plasma membrane play an important role in the clustering and activation of STIM1 
and Orai1. We find that either the small molecule D-sphingosine or mutation of the C-
terminal acidic coiled-coil of Orai1 induce punctae formation in the absence of 
colocalization of STIM1 and inhibites the STIM1-Orai1 association in response to 
thapsigargin. 
 In Chapter 3, we extend our initial identification of the C-terminal acidic 
coiled-coil of Orai1 as an important determinant of SOCE in order to identify its 
intermolecular binding partner on STIM1. We find that a short stretch of positively 
charged amino acids in the CAD domain of STIM1 is important for the interaction 
with Orai1. However, we find that when this STIM1 mutant was paired with the Orai1 
coiled-coil mutant, a residual interaction between the two proteins was restored in the 
absence of Ca2+ influx. These results suggest that the interaction between the 
positively charged sequence in the STIM1-CAD and the acidic coiled-coil of Orai1 
electrostatically gate Ca2+ influx. 
 In Chapter 4, I investigated the role of PIP2 in the interaction between STIM1 
and Orai1. Based on previous work (Vasudevan 2009), we understand that PI5KIβ and 
PI5KIγ have differential effects on SOCE, but the mechanism by which two 
functionally distinct pools of PIP2 are maintained at the plasma membrane is poorly 
understood. We find that these two PI5KI isoforms differentially enrich PIP2 in the 
DRM and DSM fractions. Using targeted PIP2 phosphatases, we find that the STIM1-
Orai1 interaction is differentially regulated by these two pools of PIP2, and we identify 
polybasic sequences on both STIM1 and Orai1 that drive this selectivity. 
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CHAPTER 2 
MOLECULAR CLUSTERING OF STIM1 WITH ORAI1/CRACM1 AT THE 
PLASMA MEMBRANE DEPENDS DYNAMICALLY ON DEPLETION OF CA2+ 
STORES AND ON ELECTROSTATIC INTERACTIONS1 
 
2.1  Abstract 
 
Activation of store operated Ca2+ entry involves stromal interaction molecule 1 
(STIM1), localized to the endoplasmic reticulum (ER), and Ca2+ channel subunit 
(Orai1/CRACM1), localized to the plasma membrane. Confocal microscopy shows 
that thapsigargin-mediated depletion of ER Ca2+ stores in RBL mast cells causes a 
redistribution of STIM1, labeled with monomeric red fluorescent protein mRFP, to 
micron-scale ER-plasma membrane junctions that contain Orai1/CRACM1, labeled 
with monomeric green fluorescent protein AcGFP. Using fluorescence resonance 
energy transfer (FRET), we determine that this visualized co-redistribution is 
accompanied by nanoscale interaction of STIM1-mRFP and AcGFP-Orai1/CRACM1. 
We find that antigen stimulation of IgE receptors causes much less Orai1/CRACM1 
and STIM1 association, but strong interaction is observed under conditions that 
prevent refilling of ER stores. Stimulated association monitored by FRET is inhibited 
by sphingosine derivatives in parallel with inhibition of Ca2+ influx. Similar structural 
and functional effects are caused by mutation of acidic residues in the cytoplasmic 
segment of Orai1/CRACM1, suggesting a role for electrostatic interactions via these 
residues in the coupling of Orai1/CRACM1 to STIM1. Our results reveal dynamic 
molecular interactions between STIM1 and Orai1/CRACM1 that depend 
                                                 
1 Reproduced with permission from Mol Biol Cell. (2009) 20, 389-99. Copyright 2009, American Society 
of Cell Biology 
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quantitatively on electrostatic interactions and on the extent of store depletion. 
 
2.2 Introduction 
 
Modulation of cytosolic Ca2+ levels is central to the regulation of a wide range of 
physiological processes. One of the key mechanisms of Ca2+ regulation in mammalian 
cells is Ca2+ release activated Ca2+ (CRAC) influx, in which the depletion of 
intracellular stores of Ca2+ triggers a sustained influx of Ca2+ from the extracellular 
medium. The CRAC current (ICRAC) was characterized initially in hematopoietic cells 
in electrophysiological studies (Lewis 1989, Hoth 1992), but the proteins that mediate 
this process eluded investigators for nearly 20 years.  
Recent advances are identification of two key proteins that regulate ICRAC: 
STIM1 that localizes to the ER and Orai1/CRACM1 that is found in the plasma 
membrane. Expression of these two proteins is sufficient to reconstitute ICRAC in 
deficient cells (Soboloff 2006). STIM1 has a Ca2+ binding, EF-hand domain 
positioned in the ER lumin (Roos 2005, Liou 2005). Orai1/CRACM1 has been 
identified as the CRAC channel in the plasma membrane (Feske 2006, Vig 2006a). 
Both STIM1 (Baba 2008) and Orai1/CRACM1 (Vig 2008) have recently been shown 
to be essential for stimulated mast cell degranulation. These discoveries have opened 
up a pathway to mechanistic understanding of ICRAC and, in particular, the 
participation of these two proteins.  
In initial studies, treatment of cells with the sarcoplasmic/endoplasmic 
reticulum Ca2+ ATPase (SERCA) inhibitor, thapsigargin, were shown to cause 
redistribution of STIM1 to form punctae at or near the plasma membrane, and these 
were identified as locations of CRAC activity (Liou 2005, Luik 2006). Mutations in 
the EF-hand domain of STIM1 resulted in constitutively active ICRAC and translocation 
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of STIM1 to the plasma membrane, indicating that this protein is the Ca2+ sensor 
responsible for transmitting the signal for store-operated Ca2+ entry (SOCE) (Liou 
2005). These results imply that these punctae are regions where ER and plasma 
membranes become closely associated, such that STIM1 can relay the signal that 
stores are empty to Orai1/CRACM1. This visualization by microscopy provides 
evidence that functionally relevant STIM1-Orai1/CRACM1 association occurs on the 
micron-scale, but it cannot specify whether direct interactions between these two 
proteins are involved in this activation mechanism. Two recent studies demonstrated 
nanoscale interactions between STIM1 and Orai1/CRACM1 as detected with 
fluorescence resonance energy transfer (FRET) in HEK cells (Muik 2008) and in T 
cells (Barr 2008).  
The present study shows that interactions between STIM1 and 
Orai1/CRACM1 occur in a highly regulated manner when SOCE is activated by IgE 
receptor stimulation of RBL mast cells. To understand this regulation we compared, 
with confocal imaging and FRET, the antigen-stimulated association of STIM1 and 
Orai1/CRACM1 under conditions where the extent of store refilling is altered: by 
elimination of extracellular Ca2+ and by treatment with Gd3+, which inhibits SOCE.  
Our results reveal that molecular interaction between STIM1 and Orai1/CRACM1 
depends dynamically on the extent of store depletion. Furthermore, inhibition of this 
interaction by sphingosine derivatives and by point mutations of acidic residues in 
Orai1/CRACM1 suggest an electrostatic mechanism involving the C-terminal segment 
of Orai1/CRACM1, providing new insights into the mechanism of antigen-mediated 
activation and regulation of ICRAC. 
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2.3  Experimental 
 
2.3.1 Cloning and Constructs.  
 
STIM1 cDNA encoded in a pcDNA4-myc-his vector was a genous gift from Monika 
Vig and Jean-Pierre Kinet (Vig 2006b).  The fusion of monomeric red fluorescent 
protein (mRFP) to the 3' end of STIM1 was constructed by cloning mRFP cDNA from 
mRFP-pRSETb plasmid (Campbell 2002), a gift from Dr. E. Cox, Princeton 
University. This cDNA was inserted into the NotI and XhoI sites of the STIM1 vector.  
A Kozac consensus sequence was inserted at the start codon to enhance expression, 
and inclusion of a stop codon on the 3' tail of mRFP prevented expression of the myc 
and his epitope tags. Orai1/CRACM1 cDNA encoded as a C-terminally FLAG-tagged 
construct in a pcDNA4 vector was a generous gift of Monika Vig and Jean-Pierrre 
Kinet (Vig 2006b). The fusion of Orai1 to the 3’ end of Aequorea coerulescens green 
fluorescent protein 1 (AcGFP) was constructed by cloning Orai1/CRACM1 from the 
pcDNA4 vector and inserting it into the BglII and KpnI sites of pAcGFP1-C1 
(Clontech). Mutants of Orai1/CRACM1 were constructed by overlap-extension PCR 
and ligated into the BglII and KpnI sites of the pAcGFP1-C1 vector. A detailed 
description of the primers involved is included in Supplemental Methods. A plasmid 
containing cDNA for the PIP2-specific PH domain from phospholipase C δ fused to 
the N-terminus of eGFP (PH-eGFP; Várnai 1998) was obtained from Dr. Andreas 
Jeromin, Allen Institute for Brain Science, Seattle WA. The construct ER-eGFP was 
constructed by ligation of the gene encoding the calreticulin ER localization sequence 
into the BglII and EcoRI sites and ligation of KDEL signal sequence into the BsrGI 
and NotI sites of pEGFP-N1 vector. 
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2.3.2 Cell culture.   
 
RBL-2H3 mast cells were cultured as monolayers in minimal essential medium 
supplemented with 1 µg/ml gentamicin and 20% (v/v) fetal bovine serum. In 
preparation for imaging, cells were harvested with trypsin/EDTA and passed at 25% 
confluence into 35 mm Mat-Tek dishes. After approximately 20 h, cells were 
transfected with fluorescent or epitope-tagged versions of STIM1 and 
Orai1/CRACM1. These constructs were co-transfected using either Geneporter 
(Genlantis) or Fugene HD (Roche) per manufacturers’ instructions, with modifications 
to enhance transfection efficiency in the RBL cells previously described (Gosse 2005). 
Cells were sensitized with IgE by incubation with 650 ng/mL monoclonal anti-DNP 
IgE overnight. Cells were imaged live or fixed 24 h after transfection.  
COS7 cells were cultured as monolayers in Dulbecco’s modified Eagle’s 
medium supplemented with 1 µg/ml gentamicin and 10% (v/v) fetal bovine serum. In 
preparation for imaging, cells were harvested and trasfected with Fugene HD  
according to manufacturer’s instructions. 
 
2.3.3 Live cell imaging.  
 
Immediately prior to imaging, RBL-2H3 cells were washed and incubated for 5 min at 
37°C in 2.5 mL buffered salt solution (BSS: 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 
5.6 mM glucose, 1 mg/ml BSA, 20 mM HEPES, pH 7.4) in the absence or presence of 
1.8 mM CaCl2, or CaCl2 with or without 6 µM GdCl3. Cells imaged in the presence of 
D-sphingosine, N,N-dimethylsphingosine (DMS) , or N,N,N-trimethylsphingosine 
(TMS) (Avanti Polar Lipids, Inc.) were treated with 0.5 mL of BSS containing the 
compound (7.6 µM final concentration) immediately prior to imaging. Cells were then 
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imaged on a Leica TCS SP2 microscope with a Leica APO 63x dipping objective. 
Cells were excited at 488 nm and 543 nm, with laser intensity and phototube 
sensitivity adjusted to maximize signal/noise. Fluorescence emission was monitored at 
495-540 nm and 555-675 nm. All live cell imaging was carried out at 37°C. After 
observing the resting state of the cells, they were stimulated by the addition of 0.5 mL 
of BSS containing thapsigargin (150 nM final concentration) or multivalent antigen 
DNP-BSA (final concentration 3 nM in BSA). Leica Confocal Software was used 
during the experiment to acquire images, and ImageJ was used post acquisition to 
prepare composite micrographs by uniform contrast adjustment. 
 
2.3.4 Calcium measurements.  
 
Immediately prior to imaging, COS7 cells were incubated with 0.9 µM fluo-4-AM 
(Molecular Probes) for 10 minutes in BSS containing 0.5 mM sulfinpyrizone. Cell 
were then washed and resuspended in BSS/sulfinpyrazone. Fields of cells were 
imaged during thapsigargin stimulation with an Olympus APO 40x dipping objective, 
under the same conditions and settings as described for multicolor imaging. The 
increase in green fluorescence in the cell body due to stimulation with thapsigargin 
was quantified using ImageJ software. For Ca2+ measurement in RBL-2H3 cells, indo-
1 was loaded and monitored in a stirred cuvette by steady-state fluorimetry as 
previously described (Pierini 1997). 
 
2.3.5 FRET imaging.   
 
RBL-2H3 cells were imaged for FRET using the imaging system and cell preparation 
described above for multicolor live cell imaging. For cells stimulated with antigen, 
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cytochalasin D (2 µM) was added immediately prior to imaging to minimize 
stimulated cell ruffling. Under these conditions, antigen stimulated Ca2+ responses are 
slightly enhanced (Pierini 1997). Cytochalasin D did not alter the FRET response to 
thapsigargin (data not shown). The Förster distance corresponding to the distance for 
50% efficiency of FRET between eGFP and DsRed is calculated to be between 47 and 
58 Å (Erickson 2003), and this is expected to be similar for AcGFP and mRFP used in 
our measurements. Cross-sectional images of cells containing both protein constructs 
were monitored for fluorescence emission at 495-540 nm for AcGFP and 575-700 nm 
for mRFP (chosen to minimize bleedthrough), using an excitation wavelength of 476 
nm. Irradiation at this wavelength provides adequate excitation of the AcGFP donor 
with negligible direct excitation of the mRFP acceptor. Laser intensity (set to 
minimize photobleaching of the donor), phototube sensitivity, and other settings 
remained constant for all FRET experiments. Throughout the time course of an 
individual experiment, images were taken simultaneously every 10 seconds for the red 
and green emission channels, and all FRET imaging was carried out at 37°C. Cells in 
2.5 ml BSS were treated with thapsigargin, DNP-BSA, CaCl2, or GdCl3 by addition of 
0.5 mL of BSS containing each, similarly to live cell imaging experiments. Cells were 
treated with D-sphingosine, N,N-dimethylsphingosine (DMS) , or N,N,N-
trimethylsphingosine (TMS) similarly by addition of 0.5 mL BSS containing the 
sphingosine derivative immediately prior to the first image collected in each FRET 
sequence.  
 
2.3.6 FRET calculations.  
 
The collected series of fluorescence images were quantified using a script written in 
Matlab to determine the degree of FRET (see Supplemental Methods). The script, 
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based on previous analyses of FRET data (Guo 1994, van Rheenen 2004), begins by 
using the green channel image at each time point to make a mask of the pixels 
containing donor fluorescence (Das 2008). Next, the integrated intensity of the pixels 
under the mask for each time point is calculated. Because the acceptor does not 
detectably co-localize with the donor prior to stimulation, the red pixel values prior to 
stimulation were attributed to bleed-through of donor fluorescence into the red 
channel. These pre-stimulation red and green integrated intensities were used to 
calculate the coefficient of bleed-through (β) by least squares analysis, accordingly to 
correct all other red channel integrated intensities for bleed-through. β was found to be 
nearly constant at approximately 0.1 for all experiments. Lastly, the corrected ratio 
between the red and green integrated intensities at each time point was calculated as a 
relative measure of FRET according to Eq 1 (van Rheenen 2004): 
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where Md is the measured donor fluorescence and MA is the measured acceptor 
fluorescence as integrated from the equatorial image at each time point. Both Md and 
MA are corrected by subtracting background pixel gray values. Time course data from 
individual cells (between 6-20 cells analyzed for each condition) were averaged, and 
these average time courses are plotted in                                                                   
Figures 2.4 and 2.5. The variation in protein expression for FRET measurements was 
quantified as a function of AcGFP fluorescence for the set of data used to calculate 
FRET after thapsigargin stimulation (Figure 2.4A). The expression levels of AcGFP-
Orai1/CRACM1 and STIM1-mRFP are highly correlated between different cells (data 
not shown), so the measured AcGFP fluorescence provides an indication of expression 
levels for both proteins. As seen in Supplemental Figure B.1, variation in the level of 
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protein expression is >3-fold for these cells, but no correlation between expression 
levels and the magnitude of stimulated FRET was observed. 
 
2.3.7 Supplemental Material.  
 
Supplemental Methods (see apendex B) include the primer sequences used in cloning, 
description of the results shown in figure B.5, supplemental figures B.1 – B.5, and the 
annotated Matlab script used to quantify image data for FRET measurement. 
  
2.4 Results 
 
2.4.1 STIM1 redistribution upon thapsigargin stimulation is accompanied by 
rearrangement of the ER in RBL mast cells.  
 
Previous reports indicated that the subcellular localization of STIM1 in unstimulated 
cells depends on microtubules (Kurosaki 2006, Mercer 2006), and that STIM1 co-
localizes with an ER marker (Liou 2005, Wu 2006). In unstimulated RBL cells, 
STIM1-mRFP substantially colocalizes with α-tubulin-eGFP (Supplemental Figure 
B.2). To evaluate spatial relationships to ER components in RBL cells, STIM1-mRFP 
and ER-eGFP, a luminally targeted protein, were transiently co-expressed. In 
unstimulated cells, STIM1-mRFP shows very limited co-localization with ER-eGFP 
largely because of its greater mictrotubule association than this luminal ER marker 
(Figure 2.1A). However, upon stimulation with thapsigargin, STIM1-mRFP and ER-
eGFP become more extensively co-localized in reticulated, micron-sized sheets of ER 
membrane (Figure 2.1B). Under these conditions, microtubule association of STIM1 
appears reduced (data not shown). Similar results are obtained when the subcellular  
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Figure 2.1: RBL mast cell expressing STIM1-mRFP (red) and ER-eGFP (green) 
exhibits stimulation-dependent changes in localization of these proteins. 
Representative cells are shown prior to (A) and after (B) stimulation with thapsigargin. 
Note the extention of the ER network throughout the cytoplasm after stimulation and 
the increased co-localization of STIM1 with the luminal ER marker. Scale bars 
indicate 10 µm.These results are consistent with ER localization of STIM1 and 
preferential association with microtubules prior to stimulation. They also show the 
capacity of thapsigargin to induce large-scale ER rearrangement. 
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Figure 2.2: Timecourse of AcGFP-Orai1/CRACM1 (green) and STIM1-mRFP 
(red) formation of co-labeled plasma membrane domains following thapsigargin 
stimulation. The patches seen in the last image, formed after 2 min of stimulation, 
remained relatively unchanged for an additional 10 min (not shown). Dorsal cell 
surface images; scale bar indicates 10 µm. 
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distributions STIM1-mRFP are compared to the endogenous luminal ER marker, 
protein disulfide isomerase, before and after thapsigargin treatment (data not shown).  
 
2.4.2 STIM1 and Orai1/CRACM1 co-redistribute to micron-sized dorsal 
membrane patches due to stimulation by thapsigargin.  
 
Previous reports documented the localization of Orai1/CRACM1 at the plasma 
membrane (Vig 2006b) and its co-redistribution with STIM1 into plasma membrane-
associated punctae in response to thapsigargin (Liu 2005, Luik 2006). We find in RBL  
cells that STIM1-mRFP and AcGFP-Orai1/CRACM1 co-redistribute into a mosaic 
pattern at the dorsal cell surface as early as 1 minute after addition of thapsigargin, and 
this pattern remains stable for more than several minutes (Figure 2.2). The time course 
we observe correlates with the time dependence of SOCE following thapsigargin-
stimulated release from stores in these cells (Glitsch and Parekh, 2000). These micron-
sized patches at the dorsal cell surface are larger than punctae initially reported for 
ventral surface confocal (Liou 2005) or TIRF images (Wu 2006), but these dorsal-
localized patches are similar in size as other STIM1-Orai1/CRACM1 patches 
observed by confocal microscopy in several recent studies in other cell types (Varnai 
2007, Smyth 2008). Moreover, using TIRF microscopy at the ventral cell surface of 
RBL cells, we observe the formation of smaller submicron scale STIM1-mRFP 
AcGFP-Orai1/CRACM1  punctae in response to thapsigargin, and these are similar to 
those observed in other studies (Liou 2005, Wu 2006) (Supplemental Figure B.3). Our 
results establish that, in response to thapsigargin, STIM1-mRFP and AcGFP-
Orai1/CRACM1 expressed transiently in RBL cells undergo large-scale co-
redistribution that is qualitatively similar to that observed for other fluorescent 
derivatives of these proteins in other cell types. 
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Figure 2.3: Confocal images of AcGFP-Orai1/CRACM1 (green) and STIM1-
mRFP (red) in dorsal slices of RBL mast cells stimulated with antigen under 
different conditions affecting Ca
2+
 influx. Cell stimulated in BSS buffer with (A) 
and without (B) CaCl2. C) Cell stimulated in BSS with Ca
2+ and 6µM GdCl3. Scale 
bars indicate 10 µm. 
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2.4.3 Antigen-stimulated co-redistribution of Orai1/CRACM1 and STIM1is 
highly restricted compared to that stimulated by thapsigargin.  
 
We found only limited co-redistribution of STIM1-mRFP and AcGFP-
Orai1/CRACM1 following stimulation mediated by IgE-receptors after crosslinking 
by multivalent antigen. Under these conditions, AcGFP-Orai1/CRACM1 remains at  
the plasma membrane and is evident in the stimulated membrane ruffles (Figure 
2.3A). Furthermore, STIM1-mRFP shows only dim localization with AcGFP-
Orai1/CRACM1 in these ruffles, and the degree of translocation to the plasma 
membrane is substantially less than that seen with thapsigargin stimulation (Figure 
2.2; see also below). This was not expected, in part because of the well-documented 
activation of ICRAC activation by antigen in RBL cells (Hoth 1992, Zhang 1995; 
McCloskey 2000). Furthermore, the Ca2+ response to antigen is 71 ± 14% of that 
caused by thapsigargin during 5 min of activation (Supplemental Figure B.4A and 
B.4B and data not shown). 
This striking difference between stimulation of STIM1-Orai1/CRACM1 co-
redistribution by thapsigargin and antigen points to differences in mechanism, and in  
particular, that thapsigargin operates by inhibiting SERCA, thereby preventing 
refilling of ER Ca2+ stores. In contrast, antigen stimulation does not impose this 
restriction. We could evaluate the significance of Ca2+ influx during antigen 
stimulation by using two different conditions to prevent it: elimination of Ca2+ in the 
extracellular buffer and addition of GdCl3 to block ICRAC (Dellis 2006). We found that 
RBL cells stimulated by antigen under either of these conditions show redistributions 
of STIM1 and CRACM1 similar to cells stimulated with thapsigargin. In the absence 
of extracellular Ca2+ (Figure 2.3B) or in the presence of 6 µM GdCl3 (Figure 2.3C), 
antigen stimulation causes STIM1-mRFP to localize to domains that also contain 
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AcGFP-Orai1/CRACM1. We confirmed that under these conditions, Ca2+ 
mobilization is substantially reduced (Figure B.4 C and D). Thus, our imaging results 
indicate that persistent store depletion is necessary for stable, large-scale co-
redistribution of STIM1 and Orai1/CRACM1. This occurs with SERCA2 inhibition by 
thapsigargin, but not with stimulation by antigen in the presence of extracellular Ca2+, 
which causes more dynamic and/or less complete store depletion.  
Equatorial confocal images clearly distinguish the distribution of these labeled 
proteins at the plasma membrane verses the cytoplasm, and similar conclusions are 
reached (Supplemental results and Figure B.5A). Furthermore, comparison of the 
distribution of AcGFP-Orai1/CRACM1 to the plasma membrane marker Alexa555-
cholera toxin B in equatorial images shows that Orai1/CRACM1 associated with 
STIM1 is localized to the non-ruffled regions of the plasma membrane (Supplemental 
Figure B.5B). Overall, our microscopy results support previous conclusions that Ca2+ 
depletion from stores causes STIM1 and Orai1/CRACM1 to co-redistribute in large 
domains at the plasma membrane, and they also shed light on the reversal or 
restriction of this process that is related to store refilling by Ca2+ influx. 
   
2.4.4 FRET measurements reveal close interactions between STIM1-mRFP and 
AcGFP-Orai1/CRACM1 that are sustained if stores are not refilled.  
 
Visualized co-localization of STIM1 with Orai1/CRACM1 at the plasma membrane 
(Figures 2.2, 2.3, and B.5A) is limited by optical resolution (>200 nm). To assess 
whether these proteins become close enough for direct interaction, we monitored 
changes in FRET from the donor AcGFP-Orai1/CRACM1 to the acceptor STIM1-
mRFP in response to stimulation. The distance sensitivity of these measurements is 
represented by the Förster distance, which for this donor-acceptor pair is estimated to 
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be ~5 nm (Erickson 2003). Equatorial images were evaluated, with an image mask to 
isolate the fluorescence associated with the plasma membrane for each cell and time 
point. The ratio of corrected red (acceptor) fluorescence to the green (donor) 
fluorescence provides a relative measure of FRET as described in Eq 1.  
Thapsigargin added to cells expressing STIM1-mRFP and AcGFP-
Orai1/CRACM1 causes a robust increase in FRET on the timescale of several minutes. 
Figure 2.4A shows this time course derived from image analyses of individual cells 
and averaged over 18 representative cells. Following a lag period of up to 100 sec, 
FRET increases to a relatively constant value with an average half time of 
approximately 180 sec. This lag most likely reflects the period during which Ca2+ in 
ER stores is reduced, and the time dependent increase in FRET intensity is consistent 
with the time course for activation of Ca2+ influx that may be limited by the rate of 
STIM1 redistribution. These FRET results are consistent with fluorescence 
micrographs showing STIM1 and Orai1/CRACM1 co-localization in response to 
thapsigargin stimulation (e.g., Figures 2.2 and B.5A), and they reveal further that these 
SOCE components from ER and plasma membrane, respectively, are interacting 
stably in close (≤10 nm) proximity under conditions where store refilling is prevented.  
An important control to distinguish measured FRET from increases in acceptor 
fluorescence due to recruitment of STIM1-mRFP to the plasma membrane is to 
substitute AcGFP-Orai1/CRACM1 with another plasma membrane-localized GFP-
labeled protein that does not associate directly with STIM1-mRFP. For this purpose, 
we used eGFP linked to the PIP2-binding pleckstrin homology (PH) domain of 
phospholipase C δ (PH-eGFP). PH-eGFP strongly localizes to the plasma membrane 
in these cells in the presence and absence of thapsigargin, similar to AcGFP-
Orai1/CRACM1 (Wu 2004; our data not shown). STIM1-mRFP, co-transfected with 
PH-eGFP and non-fluorescent Orai1/CRACM1, exhibits thapsigargin-stimulated  
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Figure 2.4: FRET between AcGFP-Orai1/CRACM1 and STIM1-mRFP in plasma 
membrane of RBL mast cells  A) FRET following addition of 150 nM thapsigargin 
(indicated by bar) to labeled cells (solid circles; error bars show SEM) as compared to 
control cells expressing PH-eGFP and unlabeled Orai1/CRACM1 instead of AcGFP-
Orai1/CRACM1 (open circles, SEM ~ 2.0 x 10-3). B) FRET following antigen 
stimulation with 3 nM DNP-BSA in BSS (SEM ~ 1.0 x10-3). C) FRET following same 
antigen stimulation but in the absence of extracellular Ca2+. CaCl2 (1.8 mM) was 
restored as indicated by bar (error bars show SEM). D) FRET after stimulation by 
antigen followed by addition of 6 µM GdCl3 (solid circles; top bars; error bars show 
SEM; solid line) or after GdCl3 addition followed by antigen stimulation (open circles; 
bottom bars; error bars omitted; dotted line). 
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translocation to patches at or near the plasma membrane, and this fluorescence is 
visualized by microscopy to be co-localized with uniformly-distributed PH-eGFP 
(data not shown). However, no change in FRET is detected between PH-eGFP and 
STIM1-mRFP in response to thapsigargin (Figure 2.4A). 
 In contrast to thapsigargin-stimulated FRET, only a small, time-dependent 
increase in FRET between AcGFP-Orai1/CRACM1 and STIM1-mRFP is caused by 
antigen (Figure 2.4B), consistent with the very limited redistribution of STIM1-mRFP 
to the plasma membrane visualized microscopically in response to antigen (Figures 
2.3A and B.5A). Because robust SOCE is observed in RBL cells after antigen 
stimulation (Figure B.4), the results indicate that efficient SOCE can be achieved with 
more limited STIM1-Orai1/CRACM1 interactions than those observed with 
thapsigargin. We hypothesize that dynamic emptying and refilling of stores that occurs 
as part of this mechanism is manifest as more transient and/or local store depletion and 
consequently more limited STIM1 redistribution to the plasma membrane. 
To test this hypothesis, we stimulated cells with antigen in the absence of 
extracellular Ca2+ to prevent refilling of stores. We observed a time-dependent 
increase to a large, sustained level of FRET between Orai1/CRACM1-AcGFP and 
STIM1-mRFP that is rapidly reversed (t½ <30s) when millimolar Ca2+ is added back 
(Figure 2.4C). This FRET measurement is again consistent with visualization by 
microscopy (Figure 2.3B and B.5A), and it further demonstrates nanoscale proximity 
of STIM1 and Orai1/CRACM1 due to receptor-mediated cell activation. Under these 
conditions, we observe redistribution of STIM1 away from the plasma membrane that 
is slower than the reversal of FRET, taking 1-3 minutes to complete (data not shown).  
This difference suggests that the rate of redistribution of STIM1-mRFP uncoupled 
from its interaction with Orai1/CRACM1 is limited by its diffusion in the ER 
membranes, consistent with recent observations of Liou et al., (2007). 
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 To investigate whether the close interaction between Orai1/CRACM1 and 
STIM1 is sensitive to Ca2+ influx mediated by ICRAC specifically, we examined the 
effect of GdCl3 on the measured FRET. After 10 min of antigen stimulation that 
caused only a small increase in FRET, addition of 6 µM GdCl3 resulted in a time-
dependent increase in FRET that approached a steady state value after 10 min and was 
similar in magnitude to that for antigen stimulation in the absence of Ca2+ (Fig. 4D, 
closed circles). Similar results were obtained when cells were pretreated with GdCl3 
and subsequently stimulated with antigen (Fig. 4D, open circles). Evidently, GdCl3-
mediated inhibition of SOCE is sufficient to sustain Orai1/CRACM1-STIM1 
interactions similarly to thapsigargin. These FRET results provide a nanoscale view of 
the interactions between Orai1/CRACM1 and STIM1 in antigen-stimulated cells that 
are dynamically regulated by ER luminal Ca2+ levels. 
 
2.4.5 D-Sphingosine and N,N-Dimethylsphingosine inhibit the association 
between STIM1 and Orai1.  
 
A previous study demonstrated the capacity of D-sphingosine and its derivative, N,N-
dimethylsphingosine (DMS) to inhibit IP3-elicited ICRAC in RBL mast cells (Mathes 
1998). To investigate whether sphingosine or DMS directly affects the interaction 
between STIM1 and Orai1/CRACM1 we measured FRET between AcGFP-Orai1 and 
STIM1-mRFP in the presence of 8 µM D-sphingosine or DMS after thapsigargin 
stimulation. These conditions are sufficient for inhibition of >60% of thapsigargin- 
stimulated Ca2+ influx by these amphiphiles (Figure 2.6A). As shown in Figure 2.5A, 
we find that both D-sphingosine and DMS strongly inhibit the interaction between 
STIM1 and Orai1/CRACM1. In contrast, N,N,N-trimethylsphingosine, the quarternary 
amine derivative of D-sphingosine, does not significantly reduce the FRET response  
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Figure 2.5: Effects of sphingosine derivatives and mutation of the Orai1 C-
terminal coiled-coil on the STIM1-Orai1 interaction. A) Thapsigargin-stimulated 
FRET between AcGFP-Orai1/CRACM1 and STIM1-mRFP in the presence of D-
sphingosine (7.6 µM, open circles), DMS (7.6 µM, closed circles; error bars omitted), 
and TMS (7.6 µM, triangles). B) Thapsigargin-stimulated FRET between STIM1-
mRFP and AcGFP-Orai1/CRACM1 (squares, same as Figure 2.4A, shown for 
comparison; error bars omitted), AcGFP-Orai1/CRACM1∆D (closed circles; error 
bars omitted), AcGFP-Orai1/CRACM1∆E (open circles), and AcGFP-
Orai1/CRACM1∆DE (triangles). Error bars show SEM.  
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Figure 2.6: Effects of sphingosine derivatives and mutation of the Orai1 C-
terminal coiled-coil on SOCE. A) Effects of sphingosine derivatives on thapsigargin 
induced Ca2+ mobilization, indo-1-monitored. Ca2+ response of suspended RBL cells 
for untreated cells (closed circles), cells in the presence of D-sphingosine (7.6 µM, 
open circles), DMS (7.6 µM, closed triangles), TMS (7.6 µM, open triangles). Every 
tenth data point is shown for clarity. B) Calcium measurements of COS7 cells 
monitored by fluo-4 imaging. Thapsigargin mediated Ca2+ mobilization is shown for 
untransfected cells (closed circles), cells expressing STIM1-mRFP with AcGFP-
Orai1/CRACM1 (open circles), AcGFP-Orai1/CRACM1∆E (open triangles), and 
AcGFP-Orai1/CRACM1∆DE (closed triangles). 
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to thapsigargin compared with untreated cells (Figure 2.4) and does not inhibit SOCE 
(Figure 2.6A). In other studies, we find that all three of these amphiphiles efficiently 
insert into the outer leaflet of the plasma membrane, but only D-sphingosine and DMS 
can flip to the inner leaflet(N. Smith, B. Baird, and D. Holowka, unpublished results), 
where they can directly interfere with the STIM1-Orai1/CRACM1 interaction. These 
results suggest the possibility of direct, electrostatic interference by D-sphingosine and 
DMS of the interaction between STIM1 and Orai1/CRACM1. The capacity of these 
positively charged lipids with different headgroup structures to similarly inhibit this 
interaction is more consistent with an electrostatic mechanism than a specific binding 
interaction.  Moreover, addition of both D-sphingosine and DMS induce the formation 
of large patches of Orai1/CRACM1 without co-localization of STIM1 (Figure 2.7A). 
Other plasma membrane proteins, such as FcεRI, do not detectably cluster under these 
conditions (data not shown). These results show that not only do these sphingosine 
derivatives disrupt the stimulated interaction between STIM1 and Orai1/CRACM1, 
but they also induce selective aggregation of Orai1/CRACM1. 
 
2.4.6 Charged amino acid residues in the C-terminus of Orai1/CRACM1 are 
important for its interaction with STIM1.  
 
A recent study provided evidence for the role of a coiled-coil domain at the C- 
terminus of Orai1/CRACM1 in the interaction between this protein and STIM1 (Muik, 
2008). This domain contains a series of three aspartates (D284, D287, and D291) and 
a separate series of three glutamates (E272, E275, and E278) predicted to be on the 
hydrophilic face of the coiled-coil. We probed the importance of charge on these 6 
amino acids by constructing three separate AcGFP-Orai1/CRACM1 mutants in which 
all three aspartates are converted to asparagine (AcGFP-Orai1/CRACM1∆D), all three  
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Figure 2.7: Sphingosine and mutation of the Orai1 C-terminal coiled-coil induce 
punctae formation. A) AcGFP-Orai1/CRACM1 in the presence of 7.6 µM D-
sphingosine exhibits plasma membrane patches without STIM1-mRFP redistribution. 
B) AcGFP-Orai1/CRACM1∆DE and STIM1-mRFP exhibits plasma membrane 
patches without STIM1-mRFP redistribution. Compare these dorsal surface images to 
Fig. 3, t=0. Scale bars indicate 10 µm. 
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glutamates are converted to glutamine (AcGFP-Orai1/CRACM1∆E), or all six acidic 
amino acids are changed to their neutral analogues (AcGFP-Orai1/CRACM1∆DE). 
We then monitored FRET between STIM1-mRFP and the AcGFP-Orai1/CRACM1 
mutants and compared this to the FRET between STIM-mRFP and wild type AcGFP-
Orai1/CRACM1 described above. As shown in Figure 2.5B, neutralization of three of 
the six acid residues resulted in an increase in thapsigargin-stimulated FRET at longer 
time points, whereas the neutralization of all six acidic residues resulted in a 
significant decrease in stimulated FRET. Moreover, cells expressing AcGFP-
Orai1/CRACM1∆DE exhibited large patches of this protein in the absence of 
stimulated clustering of STIM1, similar to cells treated with D-sphingosine or DMS 
(Figure 2.7B). These results suggest that D-sphingosine and DMS promote 
Orai1/CRACM1 clustering by neutralization of the negative charges in the putative 
coiled-coil at the C-terminus of this protein, and in so doing they prevent its 
interaction with the the C-terminus of STIM1 under cell activating conditions, 
possibly via its positively charged polybasic sequence (Li 2007).  
 
2.4.7 Charged amino acid residues in the C-terminus of Orai1/CRACM1 are 
important for functional CRAC influx.  
 
Because RBL cells have a large endogenous SOCE response, the functional 
consequences of mutations were examined in COS7 cells. The Ca2+ response to 
thapsigargin was monitored in COS7 cells transiently expressing STIM1-mRFP and 
AcGFP-Orai1/CRACM1 or one of the Orai1/CRACM1 mutants. COS7 cells exhibit 
relatively limited SOCE that is substantially enhanced by expression of STIM1-mRFP 
and AcGFP-Orai1/CRACM1 (Figure 2.6B, open circles). Potentiation of SOCE due to 
overexpression of STIM1 and Orai1/CRACM1 has been previously reported in COS7 
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cells (Varnai, 2007), and our results demonstrate the functional competence of 
STIM1-mRFP and AcGFP- Orai1/CRACM1 used in our FRET measurements. Cells 
expressing AcGFP-Orai1/CRACM1∆E show a potentiation of Ca2+ influx similar to 
that observed with wild type Orai1/CRACM1. In contrast, cells expressing AcGFP-
Orai1/CRACM1∆DE and STIM1-mRFP show only a very slow, small increase in 
Ca2+ in response to thapsigargin (Figure 2.6B). Moreover, these cells show a 
substantially delayed or reduced Ca2+ release from stores when compared to 
untransfected COS7 cells. This observation indicates that these acidic residues on 
Orai1/CRACM1 can influence the sensitivity of these cells to thapsigargin mediated 
Ca2+ release from stores. These Ca2+ mobilization results correlate with the reduction 
in FRET observed with AcGFP-Orai1/CRACM1∆DE (Figure 2.5B), indicating that 
the negatively charged residues in the C-terminus of Orai1/CRACM1 are important 
for functional SOCE.  
 
2.5 Discussion 
 
Our FRET measurements in conjunction with fluorescence confocal imaging reveal 
molecular interactions between Orai1/CRACM1 and STIM1 that are regulated by 
dynamic depletion and refilling of intracellular Ca2+ stores. Whereas thapsigargin 
inhibition of store refilling results in extensive association of Orai1/CRACM1 and 
STIM1, the SERCA-mediated store refilling that occurs normally during antigen 
stimulation substantially limits these molecular interactions. Additionally, our results 
show that store depletion results in the remodeling of the ER that accompanies 
redistribution of STIM1. STIM1 was previously identified as a transmembrane protein 
that co-localizes with the ER in unstimulated cells (Liou 2005, Wu 2006), while more 
recent studies have found STIM1 co-localization with microtubules (Kurosaki 2006, 
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Mercer 2006). Our results with RBL mast cells provide visual evidence that 
localization of STIM1 in unstimulated cells is templated to a large extent by 
microtubules, and this differs from luminal ER-localized fluorescent proteins, which 
show little or no microtubule association (Figures 2.1A and B.2).  
It is not yet clear whether STIM1 associated with microtubules is preferentially 
recruited to the plasma membrane in stimulated cells, but we observe a reduction in 
microtubule-associated STIM1-mRFP upon thapsigarin treatment (Figure 2.1 and data 
not shown). Baba et al., (2006) showed that GFP-STIM1-containing tubulovesicular 
structures rapidly move along microtubule tracks in DT40 B cells, and treatment of 
nocodazole to depolymerize microtubules halted this rapid movement but did not 
inhibit B cell receptor-stimulated SOCE. In another study, Smyth et al., (2007) 
showed that eYFP-STIM1 associates with microtubules in HEK293 cells, and that 
nocodazol inhibition substantially inhibits thapsigargin-stimulated CRAC influx in 
these cells in the absence of eYFP-STIM1 expression.  
 Our observation that intracellular localization of STIM1 changes dramatically 
upon stimulation of RBL cells with thapsigargin is consistent with results reported for 
other cell types (Liou 2005, Wu 2006). We find that the distribution of both STIM1-
mRFP and ER-eGFP appear to change, such that cytoplasmically localized STIM1-
mRFP and ER-eGFP become more extensively colocalized in the variegated network 
of the ER (Figure 2.1B). The rearrangement of the ER network upon thapsigargin 
stimulation is consistent with the previously reported role of STIM1 in the 
microtubule assisted remodeling of the ER (Grigoriev 2008). In addition to this 
cytoplasmically localized STIM1-mRFP, a pool of STIM1-mRFP redistributes to the 
plasma membrane to form an extended network that colocalizes with AcGFP-
Orai1/CRACM1 (Figure 2.2). Equatorial sections show that this network of plasma 
membrane-associated STIM1-mRFP localizes to the flat regions of the plasma 
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membrane between ruffles and other protrusions that are labeled by the plasma 
membrane marker A555-CTB (Figure B.5B). This mosaic of plasma membrane-
STIM1/ER junctions at the dorsal cell surface clearly represents a large percentage of 
the plasma membrane surface area under conditions of stimulation by thapsigargin in 
these cells. These results do not appear to be a consequence of overexpression of these 
proteins, as they are observed over a wide range of expression levels. Furthermore, 
expression of these proteins does not significantly alter Ca2+ responses to antigen or 
thapsigargin in these cells (data not shown). The size of the dorsal domains observed 
is consistent with Orai1/CRACM1-STIM1 patches reported in some other studies 
(Varnai 2007, Smyth 2008).  More discrete punctae of STIM1 are observed at the 
ventral cell surface by TIRF microscopy (Supplemental Figure B.3) similar to those 
seen in other reports in these (Liou 2007) and other cells by both confocal (Liou 2005, 
2007) and TIRF microscopy (Wu 2006, Liou 2007?).  
 To examine the molecular interactions of STIM1 and Orai1/CRACM1, we 
developed a microscopy-based FRET assay that is computationally similar to the 
membrane colocalization assay recently established in our laboratory (Das 2008). Our 
experimental system and membrane localized FRET analysis allowed the 
measurement of the interaction between STIM1-mRFP and AcGFP-Orai1/CRACM1 
with high sensitivity, temporal resolution, and reproducibility. A distinct advantage of 
the AcGFP/mRFP donor/acceptor pair is that excitation of the green donor with the 
476 nm laser line initiates energy transfer with negligible direct excitation of the red 
acceptor fluorophore, thus simplifying the FRET computation, which is targeted by 
automated masking of equatorial plasma membrane as the selected region of interest. 
Because selection of the measured regions of interest is automated on a frame-by-
frame basis, the ratiometric analysis of energy transfer (Eq. 1) is insensitive to 
variations in the focal plane and laser intensity, as well as morphological differences 
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between cells. Individual cells are imaged over time (before and after stimulation), and 
the FRET time courses for multiple cells are averaged. 
Previous TIRF imaging of thapsigargin-stimulated cells showed optical 
colocalization of labeled STIM1 and Orai1/CRACM1 in plasma membrane punctae 
(Liuk 2006), and further evidence for molecular level interactions comes from co-
immunoprecipitation of STIM1 with Orai1/CRACM1 in complexes derived from 
lysates of thapsigargin-stimulated cells (Yeromin 2006). Our FRET measurements 
demonstrate that labeled STIM1 and Orai1/CRACM1 interact closely at the plasma 
membrane of live cells as a consequence of store depletion, and they are consistent 
with these two proteins associating directly to facilitate the CRAC response. These 
measurements detect proximity on the order of 5 nm, but do not rule out the 
participation of other molecular components in this interaction. A recent study in 
HEK-293 cells provided FRET evidence interactions between STIM1-eYFP and 
eCFP-Orai1/CRACM1 following store depletion by SERCA inhibitors (Muik 2008). 
Barr (2008) detected FRET between these proteins stimulated by surface-associated T 
cell receptor ligands, but they did not compare the magnitude of this FRET to that 
induced by SERCA inhibition. In contrast, Varnai et al., (2007) showed that 
interactions between STIM1 and Orai1/CRACM1 detected by confocal microscopy 
were excluded from plasma membrane regions that were bridged to ER tethering 
proteins estimated to provide < 6 nm of inter-membrane spacing. These authors 
suggested that interactions between STIM1 and Orai1 involve additional proteins that 
extend spacing between the PM and ER to >8 nm, but alternative explanations for 
these observations, such as orientational or electrostatic interference by the bridging 
proteins, cannot be excluded. 
 Unexpectedly, antigen stimulation of RBL cells leads to STIM1 and 
Orai1/CRACM1 interactions at the plasma membrane that are highly restricted, as 
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observed with both confocal imaging (Figure 2.3A) and FRET (Figure 2.4B). The 
striking difference from thapsigargin stimulation can be explained by dynamic 
refilling of intracellular Ca2+ stores by influx that accompanies antigen stimulation and 
is prevented when the SERCA pumps are blocked by thapsigargin. Thus, dynamic 
refilling of Ca2+ stores apparently re-sets the baseline and reverses the interaction 
between STIM1 and Orai1/CRACM1. Consistent with this hypothesis, stimulation 
with antigen under conditions that prevent refilling of stores, either the absence of 
extracellular Ca2+ or the presence of Gd3+ to block CRAC-mediated Ca2+ entry, results 
in strongly enhanced interactions very similar to those observed with thapsigargin. 
Specifically, extensive co-localization of labeled STIM1 and Orai1/CRACM1 occurs 
at the plasma membrane as visualized with confocal microscopy (Figures 2.3B, C; 
B.5A) and substantially increased molecular interactions are detected with FRET 
(Figure 2.4C, D). Other recent reports are consistent with these observations. Muik et 
al., (2008) showed that FRET between STIM1-CFP and Orai1-YFP stimulated by 
agonist together with a weak SERCA inhibitor in the absence of Ca2+ was reversed by 
Ca2+ addition in HEK293 cells; Varnai et al., (2007) showed that ATP-stimulated 
STIM1 recruitment to the PM in COS7 cells was reversed by extracellular Ca2+; and 
Smyth et al., (2008) showed that carbacol-induced STIM1/Orai1 punctae formation 
detected by TIRF in HEK293 cells was reversed by Ca2+ addition. Our results 
highlight the physiological regulation of this interaction when stimulated by an 
immunoreceptor, FcεRI, during mast cell activation. 
It is notable that the kinetics of the molecular association between STIM1 and 
Orai1/CRACM1, which increases to a steady-state with a half time of several minutes, 
are similar whether Gd3+ is added before or after antigen to initiate the response 
(Figure 2.4D). Thus it appears that the rate-limiting step in this process is the 
redistribution of STIM1 to the plasma membrane, rather than preceding steps of 
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antigen-stimulated signaling. In contrast, addition of extracellular Ca2+ to antigen-
stimulated cells causes a rapid reduction in FRET, occurring with a half time of 
approximately 20 sec (Figure 2.5C), suggesting that stores are refilled very rapidly 
under these conditions. These results support the view that molecular interactions 
between STIM1 and Orai1/CRACM1 that are stimulated by antigen are highly 
dynamic and readily reversed by store refilling. Our FRET results provide a somewhat 
different picture than those of Liou et al., (2007), who monitored FRET between CFP-
STIM1 and YFP-STIM1 in RBL mast cells and observed increases that were similar 
for antigen and thapsigargin stimulation. They monitored STIM1/STIM1 interactions 
throughout the ER, and their data show that these interactions are initiated prior to 
localization of STIM1 in plasma membrane punctae. These STIM1-STIM1 
interactions possibly depend differently on store depletion/refilling than do STIM1-
Orai1/CRACM1 interactions. Direct measurement of intra-luminal free Ca2+ in the ER 
under different conditions of stimulation may help to address this question. 
Inhibition of thapsigargin-stimulated FRET between Ac-GFP-Orai1/CRACM1 
and STIM1-mRFP by D-sphingosine and DMS is consistent with the inhibitory effects 
of these amphiphiles on IP3 mediated SOC influx in RBL cells (Mathes 1998). We 
confirmed that these molecules show a similar inhibitory effect on thapsigargin 
mediated SOCE in these cells (Figure 2.6). TMS does not significantly inhibit the 
interaction between Ac-GFP-Orai1/CRACM1 and STIM1-mRFP, and it seems likely 
that D-sphingosine and DMS are effective because of the net increase in positively 
charged lipids that they provide upon flipping to the inner leaflet of the plasma 
membrane (N. Smith, unpublished results; Sato 2006). Although DMS is a well-
known inhibitor of sphingosine kinases (Yatomi 1996), it is unlikely that its effect on 
FRET depends on inhibition of this enzyme family, because the substrate for these 
enzymes, D-sphingosine, is equally effective in inhibiting FRET (Figure 2.5A) and 
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Ca2+ influx (Figure 2.6A). We hypothesize that D-sphingosine and DMS at the inner 
leaflet electrostatically interact with six acidic residues at the C-terminus of 
Orai1/CRACM1 to prevent the interaction of these residues with  STIM1 under 
conditions of CRAC activation. This model is in contrast to those published in recent 
reports by Peinelt and Smyth in which pharmacological agents disrupt the interaction 
of STIM1 with Orai1/CRACM1 by reversing the store-dependent multimerization and 
translocation of STIM1 (Peinelt 2008, Smyth 2008). It is possible that the effects of 
these positively charged amphiphiles directly prevent the association with STIM1, or 
that this effect is mediated by alteration of the lipid environment, thereby preventing 
the association of Orai1/CRACM1 with STIM1. In this regard, electrostatic 
neutralization of negatively charged phospholipids, such as phosphoinositides, by 
these positively charged amphiphiles could play a role in their mechanism of 
inhibition. The hypothesis that this effect is mediated to a large extent by electrostatic 
neutralization is bolstered by the fact that the endogenous polyamine spermine dose 
dependently inhibits FRET between the two proteins and prevents SOC influx (N. 
Calloway, unpublished results).  
Complementary to these results, we observe formation of Orai1/CRACM1 
patches at the plasma membrane following addition of D-sphingosine or DMS (Figure 
2.7). STIM1 does not co-patch under these conditions, suggesting that neutralization 
of the acidic residues by the sphingosine derivatives causes homo-oligomerization of 
Orai1/CRACM1, which could prevent its interaction with STIM1 by an effect on 
Orai1/CRACM1 structure. Importantly, SOC influx is not activated under these 
conditions (Figure 2.6A and data not shown).  
Based on the primary structure of the recently identified interacting domains of 
STIM1 and Orai1/CRACM1 (Li 2007, Muik 2008), we hypothesized that association 
of the C-terminal polybasic region of STIM1 with the acidic C-terminal coiled-coil of 
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Orai1/CRACM1 is important for the initiation of ICRAC. Thus, Orai1/CRACM1 could 
be regulated in a manner similar to some TRP channels in which a C-terminal 
polybasic region regulates the activation of channel opening by electrostatic 
interaction with the plasma membrane (for review, see Rohacs 2006). As described 
above, this model also provides an explanation for inhibition of the interaction 
between STIM1 and Orai1/CRACM1 by D-sphingosine and DMS. To test whether the 
negatively charged residues on the putative C-terminal coiled-coil of Orai1/CRACM1 
are involved in the interaction with STIM1, we mutated these residues to their neutral 
amide analogues. The results of our FRET measurements between STIM1-mRFP and 
AcGFP constructs of these Orai1/CRACM1 mutants provide clear evidence that these 
residues participate in the interaction between the two proteins (Figure 2.5B). The 
increase in FRET at long time points when only three residues are mutated could be 
the result of an altered stoichiometry between STIM1 molecules and Orai1/CRACM1 
molecules in the interacting complex. This level of reduction in charge may require 
more Orai1/CRACM1 molecules to neutralize the charge on the polybasic region of 
STIM1. However, when all six acidic residues are mutated, the stimulated FRET is 
substantially decreased, potentially because the electrostatic driving force is largely 
eliminated. Residual FRET between STIM1-mRFP and AcGFP-Orai1/CRACM1∆DE 
could be due to the presence of unmutated endogenous Orai1/CRACM1 in the 
clustered complex that interacts with clustered STIM1. Indeed, imaging of cells 
transfected with AcGFP-Orai1/CRACM1∆DE reveals the formation of patches of this 
charge-neutralized protein in the absence of stimulation. The residual interaction 
between STIM1-mRFP and AcGFP-Orai1/CRACM1∆DE detected by FRET could 
also involve other structural features of Orai1/CRACM1. Additionally, these 
mutations may affect other molecular interactions by Orai1/CRACM1, either with 
lipids or other proteins containing polybasic sequences. 
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As described above, the minimal effects of STIM1-mRFP and AcGFP-
Orai1/CRACM1 expression on the strong SOCE response of endogenous STIM1and 
Orai1/CRACM1 provide evidence that our expression system does not significantly 
alter the homeostasis of RBL cells, but it limits our capability to observe changes in 
Ca2+ influx caused by mutant Orai1/CRACM1 constructs. We therefore carried out 
these measurements in COS7 cells, which display very low levels of SOCE in 
untransfected cells (Figure 2.6B, solid circles). Consistent with previous results in 
these (Varnai 2007) and other cell types (Soboloff 2006), transient expression of 
STIM1-mRFP with AcGFP-Orai1/CRACM1 reconstituted robust SOCE (Figure 2.6B, 
open circles). However, when cells are transfected with STIM1-mRFP and AcGFP-
Orai1/CRACM1∆DE, this enhancement is dramatically reduced. These results 
confirm the functionality of the C-terminal acidic coiled-coil domain of 
Orai1/CRACM1, showing that these residues are necessary for both the interaction 
with STIM1 and the activation of Ca2+ influx. Furthermore, these results show that the 
micron-scale clustering of AcGFP-Orai1/CRACM1∆DE observed in the absence of 
STIM1-mRFP co-clustering (Figure 2.7B) does not represent functional activation of 
CRAC.  
The similarity of our findings with AcGFP-Orai1/CRACM1∆DE and with D-
sphingosine and DMS suggest a common mechanism for their effects and for the 
response to thapsigargin stimulation: Electrostatic neutralization of the C-terminal 
acidic residues of Orai1/CRACM1 by mutation, by interaction with positively charged 
D-sphingosine and DMS, and possibly by interaction with the polybasic region of 
STIM1 all induce the formation of micron-scale Orai1/CRACM1 clusters. 
Interestingly, only clustering induced by STIM1 activates ICRAC, for reasons that are 
not yet clear. 
In summary, our FRET measurements are consistent with our confocal 
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imaging and provide a direct, quantitative measure of STIM1-Orai1/CRACM1 
interactions that occur in molecular proximity in the plasma membrane of live cells. 
We observe time-dependent formation of STIM1-Orai1/CRACM1 complexes due to 
stimulation by thapsigargin or by antigen when Ca2+ influx is prevented. However, 
under normal conditions of antigen stimulation, when refilling of Ca2+ in ER stores is 
not prevented, STIM1-Orai1/CRACM1 interactions are highly regulated by store 
refilling. Furthermore, pharmacologic and mutational analyses provide evidence for an 
electrostatic mechanism for STIM1-Orai1/CRACM1 interactions and for the 
regulation of Orai1/CRACM1 oligomerization. These critical molecular interactions 
are dynamically regulated under physiological conditions of receptor-mediated Ca2+ 
mobilization. 
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CHAPTER 3 
A BASIC SEQUENCE IN STIM1 PROMOTES CA2+ INFLUX BY INTERACTING 
WITH THE C-TERMINAL ACIDIC COILED-COIL OF ORAI11 
 
3.1 Abstract  
Store-operated Ca2+ entry (SOCE) is a ubiquitous signaling process in 
eukaryotic cells in which the endoplasmic reticulum (ER)-localized Ca2+ sensor, 
STIM1, activates the plasma membrane-localized Ca2+ release-activated Ca2+ (CRAC) 
channel, Orai1, in response to emptying of ER Ca2+ stores. In efforts to understand this 
activation mechanism, we recently identified an acidic coiled-coil region in the C-
terminus of Orai1 that contributes to physical association between these two proteins, 
as measured by fluorescence resonance energy transfer, and is necessary for Ca2+ 
influx, as measured by an intracellular Ca2+ indicator. Here, we present evidence that a 
positively charged sequence of STIM1 in its CRAC channel activating domain, human 
residues 384-386, is necessary for activation of SOCE, most likely because this 
sequence interacts directly with the acidic coiled-coil of Orai1 to gate Ca2+ influx. We 
find that mutation to remove positive charges in these residues in STIM1 prevents its 
stimulated association with wild type Orai1. However, association does occur between 
this mutant STIM1 and Orai1 that is mutated to remove negative charges in its C-
terminal coiled-coil, indicating that other structural features are sufficient for this 
interaction. Despite this physical association, we find that thapsigargin fails to activate 
SOCE following co-expression of mutant STIM1 with either wt or the mutant Orai1, 
implicating STIM1 384-386 in transmission of the Ca2+ gating signal to Orai1 
following store depletion.  
                                                 
1 Reproduced with permission from Biochemistry  (2010) 49, 1067-71. Copyright 2010, American 
Chemical Society 
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3.2 Introduction 
Ca2+ release-activated Ca2+ (CRAC) channels play a key role in Ca2+ influx and 
mobilization in numerous cellular responses. These channels are activated by coupling 
of the ER-store Ca2+ sensor STIM1 (Liou 2005, Zhang 2005) to the plasma membrane 
channel protein Orai1, also known as CRACM1 (Feske 2005, Vig 2006). Recently we 
showed that six acidic residues in a putative coiled-coil at the C-terminus of Orai1 
contribute to STIM1-Orai1 interactions in response to Ca2+ store depletion (Calloway 
2009). The mutant lacking these acidic residues, Orai1∆DE, exhibits a clustered 
distribution at the plasma membrane in the absence of and following stimulation with 
thapsigargin. Similar clustering of wtOrai1 in unstimulated cells is caused by 
sphingosine derivatives that flip to the inner leaflet of the plasma membrane 
(Calloway 2009), suggesting that electrostatic repulsion prevents homo-
oligomerization of unliganded Orai1. Stimulated oligomerization of Orai1 that is 
induced by clustered STIM1 is known to play a role in channel activation (Liou 2007, 
Penna 2008).  
Based on these results, we hypothesized that electrostatic attraction and 
resulting neutralization of the acidic coiled-coil in Orai1 by basic residues in STIM1 
facilitates oligomerization of Orai1 necessary for activation of the complex in 
response to store depletion. We therefore sought to identify a sequence on STIM1 that 
could mediate this charge neutralization. We first considered that the C-terminal 
polybasic sequence of STIM1 could be responsible for this coupling. However, our 
findings and those of others (Kawasaki 2009, Park 2009, Yuan 2009) demonstrated 
that this region is not necessary for robust SOCE or for formation of the STIM1-Orai1 
complex. Furthermore, STIM1 residues 342-448 (human numbering), named the 
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CRAC activating domain (CAD), was recently identified as a minimal region of 
STIM1 sufficient to activate Ca2+ mobilization (Park 2009, see also Kawasaki 2009, 
Yuan 2009). Motivated by this information, we identified a short, highly conserved, 
basic sequence within CAD, STIM1 (382-387), as a potential region for interaction 
with the Orai1 acidic coiled-coil. We used fluorescence resonance energy transfer 
(FRET) and Ca2+ mobilization measurements of mutants to show that these residues 
are key for functional coupling of STIM1 and Orai1. 
 
3.3 Experimental 
 
3.3.1 Constructs and cloning 
 
 STIM1 K(384-6)Q-mRFP cDNA was generated using the Stratagene 
Quickchange site-directed mutagenesis kit on our previously constructed STIM1-
mRFP vector (Calloway 2009). The primers used are: 5’-
GCCAAGGAGGGGGCTGAGAAGATACAACAGCAGAGAAACACACTCTTTG
GCACCTTCCAC-3’ and its reverse complement. Preparation of the constructs 
AcGFP-Orai1 and AcGFP-Orai1∆DE was previously described (Calloway 2009). 
 
3.3.2 Cell culture 
 
 RBL-2H3 mast cells were cultured in minimal essential medium supplemented with 1 
µg/ml gentamicin and 20% (v/v) fetal bovine serum. In preparation for transfection 
and imaging, cells were plated at 25% confluence into 35 mm MatTek wells. After 
approximately 20 h, cells were transfected with either mutant or wild-type versions of 
STIM1-mRFP and AcGFP-Orai1. These constructs were transfected using either 
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Geneporter (Genlantis) or Fugene HD (Roche) per manufacturers’ instructions, with 
modifications to enhance transfection efficiency in the RBL cells previously described 
(Gosse 2005). Cells were imaged 24 h after transfection.  
COS7 cells were cultured as monolayers in Dulbecco’s modified Eagle’s 
medium supplemented with 1 µg/ml gentamicin and 10% (v/v) fetal bovine serum. In 
preparation for imaging, cells were harvested and transfected with wt or mutant 
mRFP-STIM1 and Orai1 using Fugene HD according to manufacturer’s instructions. 
Cells were transfected with non-fluorescent derivatives of Orai1 and mRFP-labeled 
derivatives of STIM1 as a marker for positive transfectants. Cells were imaged 24 h 
after transfection. 
 
3.3.3 Confocal Microscopy 
 
Immediately prior to imaging, RBL-2H3 cells were washed and incubated for 5 min at 
37°C in 2.5 mL buffered salt solution (BSS: 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 
1.8 mM CaCl2, 5.6 mM glucose, 1 mg/ml BSA, 20 mM HEPES, pH 7.4). Cells were 
then imaged on a Leica TCS SP2 confocal microscope with a Leica APO 63x dipping 
objective. Cells were excited at 488 nm and 543 nm, with laser intensity and 
phototube sensitivity adjusted to maximize signal/noise. Fluorescence emission was 
monitored at 495-540 nm and 555-675 nm. All live cell imaging was carried out at 
37°C. After observing the resting state of the cells, they were stimulated for the time 
specified by the addition of 0.5 mL of BSS containing thapsigargin (150 nM final 
concentration). Leica Confocal Software was used during the experiment to acquire 
images, and ImageJ was used post acquisition to prepare composite micrographs by 
uniform contrast adjustment. 
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3.3.4 Ca
2+
 Measurements 
 
Immediately prior to imaging, COS7 cells were incubated with 0.9 µM fluo-4-AM 
(Molecular Probes) for 10 minutes in BSS containing 0.5 mM sulfinpyrazone. Cells 
were then washed and resuspended in BSS/sulfinpyrazone. Fields of cells were 
imaged before and during thapsigargin stimulation under the same conditions and 
settings as described for multicolor imaging. For single-cell time courses, images were 
collected every 15 seconds for 2.5 min prior to stimulation and for 10 min after 
thapsigargin stimulation. For quantitation of pre- and post-stimulation Ca2+ levels, 
several fields of cells were imaged before stimulation and 10 minutes after 
thapsigargin stimulation. Cytoplasmic Fluo-4 fluorescence was quantified using 
ImageJ software. For each dish of cells, the average prestimulation fluorescence in 
untransfected cells was normalized to 1.0 to account for small differences in dye 
loading between multiple samples. 
 
3.3.5 FRET Measurement 
 
RBL-2H3 cells were imaged for FRET as previously described (Calloway 2009). 
Briefly, cells expressing a combination of mutant or wild-type STIM1-mRFP and 
AcGFP-Orai1 were imaged at 10 second intervals with excitation at 476 nm to 
minimize spectral bleedthrough. An automated mask-drawing algorithm in Matlab 
was used to select the pixels of interest at the plasma membrane for every time point 
using fluorescence from AcGFP as the template. The integrated red and green 
intensities under the mask were adjusted by background subtraction and correction for 
spectral bleedthrough. We report the ratio of the corrected red fluorescence to 
corrected green fluorescence as FRET (Calloway 2009).  
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3.4 Results and Discussion 
 
The majority of the STIM1 CAD sequence shows homology to coiled-coil regions 
from a wide array of proteins (based on homology search using the Position-Specific 
Iterated Basic Local Alignment Search Tool, PSI-BLAST, provided by the NIH, 
http://blast.ncbi.nlm.nih.gov/Blast.cgi), but residues 382-395 have lower sequence 
homology to other proteins, suggesting a specialized function of this segment. We 
therefore mutated the three central lysines in this sequence (384-386) to glutamines to 
eliminate their positive charge while maintaining the hydrophilic and steric character 
of the endogenous sequence (STIM1 K(384-6)Q). Our modeling predicts that the 
flanking basic residues (K382 and R387) in this sequence are involved in 
intramolecular salt bridges with neighboring acidic amino acids and therefore might be 
of structural importance. The sequence we selected is similar to a slightly longer 
sequence of homologous, positively charged amino acids in the CAD region of the 
Bombyx mori (silkmoth) homologue of STIM1 that was recently shown to be 
important for translocation of STIM1 to plasma membrane punctae (Hull 2009). It is 
very close to residue L373 that was identified by Fischauf et al. as being critical both 
for the interaction of STIM1 and Orai1 and for Ca2+ mobilization (Frischauf 2009). 
We speculate that the mutation STIM1 L373S may disrupt the coiled-coil structure in 
the segment of STIM1 containing the basic residues we identified, thereby preventing 
proper engagement with Orai1. 
We previously developed a microscopy-based FRET assay to monitor the 
physical association of wtSTIM1-mRFP with AcGFP-wtOrai1 and AcGFP-Orai1∆DE  
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Figure 3.1: Thapsigargin-mediated FRET. Thapsigargin (150 nM)-stimulated 
FRET between STIM1-mRFP and AcGFP-Orai1 constructs in RBL mast cells. 
wtSTIM1-mRFP and AcGFP-wtOrai1 (black line), wtSTIM1-mRFP and AcGFP-
Orai1∆DE (mut-Orai1; grey line), STIM1 K(384-6)Q-mRFP (mut-STIM1) and 
AcGFP-Orai1∆DE (○), and STIM1 K(384-6)Q-mRFP and AcGFP-wtOrai1 (●). Error 
bars show SEM for 12 to 18 cells from 4-5 different experiments, and every fifth error 
bar is shown for clarity. 
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(Calloway 2009). Using this method, we measured FRET between STIM1 K(384-6)Q-
mRFP and AcGFP-wtOrai1 transfected into RBL mast cells. We found that these 
mutations in STIM1 almost completely prevent its association with wtOrai1 that is 
normally observed following stimulation by thapsigargin (Figure 3.1). In unstimulated 
cells, STIM1 K(384-6)Q-mRFP is expressed similarly to wtSTIM1-mRFP throughout 
the ER (Figure 3.2A,C) (Calloway 2009). However, unlike wt-STIM1-mRFP, this 
mutant fails to undergo thapsigargin-stimulated co-clustering with AcGFP-wtOrai1 in 
plasma membrane punctae (Figure 3.2D), consistent with the FRET results. Also 
shown in Figure 3.2A is the punctate distribution of AcGFP-Orai1∆DE at the plasma 
membrane of this unstimulated RBL cell as previously described (Calloway 2009). To 
evaluate the functional capacity of this STIM1 mutant, we monitored Ca2+ 
mobilization in COS7 cells using Fluo-4 as previously described (Calloway 2009). 
COS7 cells exhibit little or no endogenous SOCE, but they exhibit a robust response 
to thapsigargin when wtSTIM1-mRFP and wtOrai1 are co-expressed (Figure 3.3A, 
blue circles). In contrast, when STIM1 K(384-6)Q-mRFP is co-expressed with 
wtOrai1 at similar levels, no thapsigargin-stimulated SOCE is observed (Figure 3.3A, 
green triangles). Results in Figures 3.1 and 3.3 indicate that STIM1 lysine residues 
384-386 are necessary for coupling to Orai1 and consequent activation of SOCE. 
These observations, together with our previous results, led us to hypothesize that basic 
residues 384-386 of STIM1 directly engage the acidic coiled-coil at the C-terminus of 
Orai1, involving electrostatic attraction between the oppositely charged residues. If 
this is the case, wtOrai1 might not couple with STIM1 K(384-6)Q without this 
electrostatic attraction. Alternatively, electrostatics may contribute but may not be the 
dominant energetic contribution to the interaction between STIM1 and Orai1. In this 
latter case, the stimulated association of the wild type proteins might be restored if the 
charged sequences on both of these proteins are mutated to neutral amino acids. To 
 70 
distinguish these possibilities, we measured FRET between STIM1 K(384-6)Q-mRFP 
and AcGFP-Orai1∆DE, and we found that thapsigargin stimulates their physical 
association to a similar extent as for the wild type proteins, but with substantially 
slower kinetics (Figure 3.1). This finding is similar to the slow FRET-detected 
association between wtSTIM1-mRFP and AcGFP-Orai1∆DE that we previously 
reported (Calloway 2009; Figure 3.1). Consistent with the FRET observed, STIM1 
K(384-6)Q-mRFP co-patches with AcGFP-Orai1∆DE in plasma membrane punctae in 
response to thapsigargin, similar to that seen with wtSTIM1-mRFP and AcGFP-
Orai1∆DE (Figure 3.2B,F). As with FRET-detected association, this visible co- 
patching of STIM1 K(384-6)Q-mRFP with AcGFP-Orai1∆DE requires longer 
stimulation times with thapsigarin than for the corresponding wt constructs. 
This finding that STIM1 K(384-6)Q undergoes stimulated association with Orai1∆DE, 
but does not associate with its wild-type partner, suggests a model for the interaction 
between these two proteins and the role of the charged sequences in this interaction 
(Figure 3.4). Although the charged sequence on STIM1 and its resulting electrostatic 
attraction to the acidic sequence on Orai1 appears to contribute little to the overall 
binding energy of the active complex, mutation to eliminate the charged residues on 
STIM1 clearly reduces the interaction energy with its wild type partner. Thus, the 
simplest model to account for these observations is one in which this acidic sequence 
on Orai1 normally interacts with the basic sequence on STIM1 in an attractive 
electrostatic interaction. 
To determine whether stimulated association between STIM1 K(384-6)Q and 
Orai1∆DE results in SOCE, we monitored Ca2+ mobilization in COS7 cells expressing 
these mutants. As shown in Figure 3.3A, we did not detect a significant Ca2+ response 
to thapsigargin (red squares), compared to untransfected COS7 cells (pink circles).  
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Figure 3.2: Cellular distributions of Orai1 and STIM1. Ventral surface confocal 
microscopy images of transfected RBL cells showing distributions of (A-B) AcGFP-
Orai1∆DE (green) and wtSTIM1-mRFP (red), (C-D) AcGFP-wtOrai1 (green) and 
STIM1 K(384-6)Q-mRFP (red), or (E-F) AcGFP-Orai1∆DE and STIM1 K(384-6)Q-
mRFP in the absence (A,C,E) or presence (B,D,F) of 150 nM thapsigargin for 30 min 
at 37oC. Scale bars represent 10 µm. 
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Figure 3.3:  Stimulated Ca2+ responses. A) Ca2+ responses to 150 nM thapsigargin in 
COS7 cells expressing wtSTIM1-mRFP and wtOrai1 (●), STIM1 K(384-6)Q-mRFP 
and wtOrai1 (▼), wtSTIM1-mRFP and Orai1∆DE (▼), STIM1 K(384-6)Q-mRFP 
and Orai1∆DE (■), and untransfected cells (●). Fluo-4 fluorescence was normalized 
relative to the average prestimulation basal Ca2+ level in untransfected cells in the 
same field. Each time course represents the average of 10-18 cells, and error bars 
show SEM. Cells with basal Ca2+ levels >3x larger than the average for untransfected 
cells were excluded. B) Mean Ca2+ levels before and 10 min after addition of 150 nM 
thapsigargin for averaged individual COS7 cells expressing a combination of 
wtSTIM1-mRFP or mutant STIM1 K(384-6)Q-mRFP  with wtOrai1 or mutant 
Orai1∆DE. Each bar represents the mean for 20-60 cells from 3 or more different 
experiments, and error bars show SEM. 
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The absence of SOCE with these constructs, which clearly undergo thapsigargin-
stimulated association detected by FRET (Figure 3.1) and co-patching (Figure 3.2F),  
implicates these sequences in the gating of Ca2+ influx. Our proposed model accounts 
for these results: Ca2+ gating is controlled by the C-terminal acidic coiled-coil of 
Orai1, and engagement of this sequence with basic residues 383-387 in the CAD 
region of STIM1 induces the formation of the active CRAC channel (Figure 3.4A). 
Our previous results provided evidence that the acidic coiled-coil of Orai1 
controls its oligomerization state, possibly based on mutual electrostatic repulsion (5). 
In our current model, STIM1 facilitates Ca2+ mobilization in part by inducing the 
oligomerization of Orai1. Modulation of electrostatics at the faces of coiled-coils has 
been implicated previously in the control of the oligomerization state of different 
proteins (Woolfson 2005, Fairman 1996), consistent with our view that, by 
neutralizing the acidic coiled-coil on Orai1, STIM1 383-387 reduces the charge-
charge repulsion between individual Orai1 monomers and allows them to oligomerize 
into an active state. Our model is also consistent with our observations that 
neutralization of the acidic residues on the C-terminal coiled-coil of Orai1 induces 
plasma membrane patching of this protein in the absence of store depletion or STIM1 
translocation (Figure 3.2A) (Calloway 2009).  
We investigated possible Ca2+ influx through spontaneous oligomerization of 
Orai1∆DE. Figure 3.3B summarizes average Ca2+ levels before and 10 min after 
addition of 150 nM thapsigargin for a large number of individual cells. For 
unstimulated cells, there is a small but significant increase in the average Ca2+ levels 
of cells expressing Orai1∆DE compared to untransfected cells or cells transfected with 
wtOrai1. We find that a small fraction (~10-20%) of these cells have a basal state of 
cytoplasmic Ca2+ that is >3-fold above that of untransfected cells, suggesting they 
have spontaneously activated CRAC channels (supplemental Figure C.1A). However, 
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cells expressing Orai1∆DE with both high and low resting Ca2+ levels are similarly 
unresponsive to thapsigargin, consistent with the incapacity of Orai1∆DE  to be 
activated by STIM1 (Figure C.1B). This variation in resting Ca2+ levels we observe for 
cells expressing clustered Orai1∆DE indicates that there must be additional factor(s) 
controlling the gating of Ca2+ entry through Orai1 that varies among cells; one 
possibility is population differences in polyphosphoinositide levels (Vasudevan 2009). 
To account for the activation of SOCE, we propose that, in addition to 
inducing Orai1 oligomerization, binding of the STIM1 K(384-386) sequence to the 
acidic residues in the coiled-coil of Orai1 causes an allosteric change that directly 
opens the Ca2+ selective pore in the STIM1-Orai1 complex. Park et al. showed that 
STIM1 CAD interacts with both the N and C termini of Orai1 (Park 2009). A possible 
scenario is that the C-terminal acidic coiled-coil of Orai1 interacts with its own N-
terminus in the resting state, and STIM1 (346-348) disengages this interaction in 
activated cells, thereby opening the channel in an allosteric manner (Figure 3.4A). The 
N-terminus of Orai1 contains a poly-arginine sequence (Orai1 28-33) that could serve 
as a potential binding partner for its acidic coiled-coil in unstimulated cells. Yuan, et 
al. found that the N-terminus of Orai1 is important for activation of CRAC channels 
with full length STIM1, but not with a minimal interaction domain that is similar to 
CAD (Yuan 2009), suggesting additional changes in Orai1 structure may be involved 
in this activation process.  
In summary, we find that the basic sequence in the C-terminus of STIM1, 
K384-386, is important for functional coupling of STIM1 with Orai1 that is driven by 
thapsigargin-mediated Ca2+ store depletion (Figure 3.4A,B). Futhermore, we 
demonstrate that mutation to neutralize acidic residues in the C-terminal coiled-coil of 
Orai1 restores its stimulated association with STIM1 K(384-6)Q, but does not restore 
SOCE (Figure 3.4C). Our results support a model in which both oligomerization of 
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Figure 3.4: Cartoon depicting basic features of proposed model for wild type and 
mutant STIM1 and Orai1 interactions. A) In unstimulated cells, the negatively 
charged acidic amino acids on wtOrai1 and the positively charged lysine sequence 
(K384-386) in the STIM1 CAD domain (dark grey) defined by our mutations are 
shown associated with solvated counter ions. Upon stimulation, these ions are 
displaced from the binding cleft between the two proteins, allowing these charged 
regions to interact with each other and causing the Ca2+-selective channel to open in 
an allosteric manner. B) When K384-386 in STIM1 is mutated to glutamines, STIM1 
no longer binds and activates wtOrai1 due to the loss of electrostatic attraction and 
resulting repulsion at this interaction subsite. C) When these charged sequences on 
Orai1 and STIM1 are both mutated, STIM1 CAD regains the capacity to bind Orai1 
via interactions at other sites because the electrostatic repulsion has been eliminated. 
However, this association does not cause allosteric activation of the Ca2+ gate. The 
oligomerization state of these proteins is omitted for clarity: Orai1 is oligomerized in 
the active wtSTIM-wtOrai1 complex and in all cases involving Orai1∆DE. 
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Orai1 and Ca2+ gating are dependent on electrostatic interaction between these 
sequences in Orai1 and STIM1. In addition, our results reveal that these two processes 
can be uncoupled from each other in this exquisitely regulated mechanism of SOCE 
activation.  
 
3.5 Supporting Information Available:   
 
Figure C.1. Population distribution of Ca2+ levels in cells expressing mutant and wild 
type STIM1 and Orai1. This material is included in appendix C. 
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CHAPTER 4 
STIMULATED ASSOCIATION OF STIM1 AND ORAI1 IS REGULATED BY 
THE BALANCE BETWEEN DETERGENT RESISTANT AND DETERGENT 
SOLUBILIZED POOLS OF PIP2 
 
4.1 Abstract 
 
We previously showed that PI5KIβ and PI5KIγ generate functionally distinct pools of 
phosphotidylinositol-(4,5)-bisphosphate (PIP2) important for inositol trisphosphate 
(IP3) production and Ca
2+ mobilization, respectively (Vasudevan, L., Jeromin, A., 
Volpicelli-Daley, L., De Camilli, P., Holowka, D., and Baird, B., 2009, J Cell Sci. 
122, 2567-74). In the present study, we demonstrate that the FRET detected 
interaction between the ER Ca2+ sensor, STIM1, and the store operated Ca2+ (SOC) 
channel, Orai1, following store depletion with thapsigargin is enhanced by 
overexpression of PI5KIβ and inhibited by overexpression of PI5KIγ. We also show 
that overexpression of these different isoforms results in the differential enhancement 
of PIP2 in detergent-resistent membrane (DRM) and detergent-solubilized membrane 
(DSM) fractions. These biochemically extracted DRM and DSM fractions correspond 
roughly to membrane domains characterized by ordered lipids and disordered lipids, 
respectively.   Over-expression of inositol 5-phosphatase L10-Inp54p that targets to 
ordered lipids causes depletion of PIP2 from the DRM fraction, and also inhibits 
thapsigargin-mediated STIM1-Orai1 association. On the other hand, Over-expression 
of inositol 5-phosphatase S15-Inp54p that targets to disordered lipids causes depletion 
of PIP2 from the DSM fraction, and this treatmentenhances STIM1-Orai1 association. 
Removal of either the STIM1 C-terminal polylysine sequence (a.a. 677-685) or a N-
terminal polyarginine sequence in Orai1 (a.a. 28-33) interferes with the differential 
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sensitivity of the STIM1-Orai1 association to the concentrations of PIP2 that isolate 
with DRM and DSM fractions. These results are consistent with a model in which, 
following Ca2+ store depletion, Orai1 translocates between structurally and 
functionally distinct membrane domains in a PIP2-dependent fashion to engage STIM1 
associated with the ordered lipid pool of PIP2. 
 
4.2 Introduction 
 
Store-operated Ca2+ entry (SOCE) is a ubiquitous process that regulates intracellular 
Ca2+ as a secondary messenger in nonexcitable cells. The two proteins that are 
necessary for this process are the ER transmembrane Ca2+ sensor STIM1 (Liou 2005, 
Zhang 2005) and the plasma membrane tetraspan Ca2+ channel Orai1, also known as 
CRACM1 (Feske 2006, Vig 2006). Oligomerized Orai1 forms the Ca2+ release-
activated Ca2+ (CRAC) channel that is activated by association with STIM1 at ER-
plasma membrane (ER-PM) junctions following depletion of Ca2+ from the ER, 
resulting in Orai1-mediated influx of Ca2+ from the extracellular medium. We 
identified an acidic coiled-coil on the C-terminus of Orai1 as important for the 
functional interaction between STIM1 and Orai1 (Calloway 2009), and in a 
subsequent study we showed that a short sequence of lysine residues within the CRAC 
activating domain (CAD; Park 2009) of STIM1 must interact with the acidic coiled-
coil of Orai1 for functional coupling (Calloway 2010). 
 In addition to these sequences, the lysine rich C-terminus of STIM1 (hu a.a. 
677-685) has been a region of much interest for its hypothesized capacity to bind 
phosphatidylinositol phosphates (PIPs) at the plasma membrane in a STIM1 
oligomerization-enhanced mechanism (Liou PNAS 2007). Korzeniowski, et al. (2009) 
demonstrated that activation of the CRAC current (ICRAC) is sensitive to inhibition of 
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phosphatidylinositol 4-kinase, but is not prevented by depletion of PIP2 at the plasma 
membrane. Walsh et al. (2010) showed that inhibition of multiple pathways of PIP2 
generation is necessary to prevent thapsigargin-mediated translocation of STIM1 to 
the plasma membrane, but that expression of Orai1 permits STIM1 to concentrate at 
ER-PM junctions even in the absence of PIP2. Furthermore, they showed that PIP2 can 
play an inhibitory role in the interaction of Orai1 with STIM1 (Walsh 2010). 
Additionally, several studies have provided evidence for roles for the C-terminal 
polylysine sequence of STIM1 in other interactions. This polylysine sequence has 
been identified as a direct binding partner for canonical transient receptor potential 
(TRP) channels (Zeng 2008), as a structural determinant of the inwardly rectifying 
character of ICRAC (Yuan 2009), and as a binding site for calmodulin (Bauer 2008).  
We previously demonstrated that different isoforms of type I 
phosphatidylinositol-4-phosphate 5-kinase (PI5KI), namely PI5KIβ and PI5KIγ, 
synthesize functionally distinguishable pools of phosphatidylinositol-4,5-bisphosphate 
(PIP2) that have distinct roles in SOCE and inositol trisphosphate (IP3) generation, 
respectively (Vasudevan 2009). In the current study we have characterized the 
membrane structure basis for these multiple pools of PIP2, and we have illuminated 
their roles in the regulation of SOCE. Previous studies provided evidence for a role for  
ordered lipid membrane domains, known as “lipid rafts”, in the interaction between 
STIM1 and TRPC1 (Pani 2008, Alicia 2008) In the present study, we find evidence 
that the C-terminal polylysine sequence of STIM1, as well as a previously 
uncharacterized poylarginine sequence in Orai1 (hu a.a. 28-33) modulate STIM1-
Orai1 association during SOCE by their differential association with PIP2 pools in 
ordered and disordered membrane domains. 
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4.3 Experimental 
 
4.3.1 Constructs and cloning 
 
STIM1∆K-mRFP was constructed from our previously described STIM1-mRFP 
vector (Calloway 2009) using the Stratagene Quickchange site directed mutagenesis 
kit. The primers used are 5’-GGAAACAGACTCCAGCCCAGGCC 
GGGCGGCCGCATCAGGCATGGCCTC-3’ and its reverse complement. AcGFP-
Orai1∆R was constructed using site-directed mutagenesis on our previously described 
AcGFP-Orai1 vector (Calloway 2009). The mutagenic primers used are 5’- 
GCAGCACCACCAGCGGCAGCAGCGGGGACGGGGAGCCC-3’ and its reverse 
complement. Additionally, flanking primers up and downstream of the multiple 
cloning site on AcGFP-Orai1 were used. 
L10-Inp54p and S15-Inp54p were derived from the L10-GFP-Inp54p and S15-
GFP-Inp54p vectors from Dr. William Rodgers (Johnson 2008). GFP was removed 
from each vector by recloning and ligating the targeting sequence (L10 or S15) with 
that for Inp54p. PI5KIβ, PI5KIγ87, STIM1-mRFP, and AcGFP-Orai1 vectors were 
previously described (Vasudevan 2009, Calloway 2009). 
 
4.3.2 Cell Culture 
 
RBL-2H3 mast cells were cultured in minimal essential medium supplemented with 1 
µg/ml gentamicin and 20% (v/v) fetal bovine serum. In preparation for transfection 
and imaging, cells were plated at 25% confluence into 35 mm MatTek wells. After 
approximately 20 h, cells were transfected with either mutant or wild-type versions of 
STIM1-mRFP and AcGFP-Orai1. These constructs were transfected using either 
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Geneporter (Genlantis) or Fugene HD (Roche) per manufacturers’ instructions, with 
modifications to enhance transfection efficiency in the RBL cells previously described 
(Gosse 2005). Additionally, modifications were made to the transfection protocol to 
achieve higher degrees of expression for both the L10-Inp54p and S15-Inp54p 
constructs: cells were transfected with 8 µg DNA (7 µg Inp54p construct, 0.5 µg each 
of STIM1 and Orai1 constructs) and 20 µL Geneporter in 100 µL OptiMem 
(Invitrogen) added to each MatTek well. Cells were imaged 24 h after transfection. 
For Ca2+ measurements in RBL-2H3 cells, indo-1 was loaded and monitored in a 
stirred cuvette using steady-state fluorimetry as previously described (Pierini 1997). 
 
4.3.3 Confocal Microscopy and FRET 
 
RBL-2H3 cells were imaged for FRET as previously described (Calloway 2009). Prior 
to imaging, RBL-2H3 cells were washed and incubated for 5 min at 37°C in 2.5 mL 
buffered salt solution (BSS: 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 
5.6 mM glucose, 1 mg/ml BSA, 20 mM HEPES, pH 7.4). Images of cells were 
collected on a Leica TCS SP2 confocal microscope with a Leica APO 63x dipping 
objective. Cells were excited at 488 nm and 543 nm, with laser intensity and 
phototube sensitivity adjusted to maximize signal/noise. For FRET measurements, 
cells were imaged at 10 second intervals with excitation at 476 nm to minimize 
spectral bleedthrough. All FRET measurements were carried out at 37°C. After 
observing the resting state of the cells, they were stimulated for the time specified by 
the addition of 0.5 mL of BSS containing thapsigargin (150 nM final concentration). 
An automated mask-drawing algorithm in Matlab was used to select the pixels of 
interest at the plasma membrane for every time point using fluorescence from AcGFP 
as the template (Calloway 2009). The integrated red and green fluorescence intensities 
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under the mask were adjusted by background subtraction and correction for spectral 
bleedthrough. We report the ratio of the corrected red fluorescence to corrected green 
fluorescence as FRET. 
 
4.3.4 Membrane Fractionation and Dot-Blots 
 
24 h prior to fractionation, cells were electroporated with the indicated construct at a 
concentration of 32 µg DNA/mL at 280 V and 950 µF using Gene Pulser X (Bio-Rad). 
Sucrose gradient fractionation was performed as previously described (Field 1999), 
with small modifications. Briefly, cells were harvested, resuspended in BSS, and 
solublized with Triton X-100 (Pierce) at a ratio of 0.013 % (v/v) Triton X-100 per 1 x 
106 cells. Gradients were constructed by pipetting in order: 250 µL 80% sucrose, 500 
µL 50% sucrose, 1.5 mL 40% sucrose containing cell lysate, 750 µL 30% sucrose, 500 
µL 20% sucrose and 1 mL 10% sucrose (all concentrations are w/v). After 16-18 h of 
centrifugation at 49,000 rpm, each gradient was divided into two fractions at the top 
interface of the 40% sucrose band. Each of these fractions was subsequently extracted 
for lipids via the method described by Johnson, et al. (2008). After extraction, the 
dried lipid film was resuspended in water at a concentration normalized to 800 cell 
equivalents/µL. Dot-blotting was performed by first sealing the ventral holes in the 
dot-blot apparatus (BD Biosciences) with aluminum foil. Then 10 µL of resuspended 
extract was added to the nitrocellulose membrane in each well and allowed to air dry 
in the apparatus for 30 min, followed by removal of the membrane from the aparatus 
and further drying 1.5 h at ambient temperature. Blots were blocked in either 3% BSA 
(w/v) or 20% FBS (v/v), developed with anti-PIP2 mAb (Assay Designs) and anti-
mouse IgG conjugated to horseradish peroxidase (GE Healthcare). Blots were 
visualized using Supersignal West Pico chemiluminescent dye (Thermo Scientific). 
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Quantification was performed with ImageJ. 
 
4.4 Results 
 
4.4.1 Cholesterol and phosphoinositides contribute to stimulated association of 
STIM1 and Orai1. 
 
Previous studies provided evidence for a role for cholesterol-dependent membrane 
heterogeneity in the activation of SOCE involving TRP channels (Pani 2008, Jardin 
2008). As shown in Figure 4.1A, we find that relatively mild cholesterol depletion 
from RBL mast cells by 4 mM methyl β-cyclodextrin (MβCD) for 20 min at 37°C 
results in substantial inhibition of thapsigargin-stimulated SOCE. Under these 
conditions, cholesterol is reduced by approximately 30% in these cells (Surviladze 
2001), and in multiple experiments, we find that SOCE measured 5 min after addition 
of thapsigargin is inhibited by 69 ± 6 % (SD, n=3). Sensitivity of this Ca2+ influx to 1 
µM Gd3+ indicates that this is largely due to ICRAC (Broad 1999). We previously 
established a method to monitor the stimulated association of STIM1 and Orai1 by 
fluorescence resonance energy transfer (FRET). Using this method in RBL cells 
transiently transfected with donor AcGFP-Orai1 and acceptor STIM1-mRFP, we find  
that similar mild cholesterol depletion by MβCD inhibits thapsigargin-stimulated 
association of STIM1 with Orai1 by 73 ± 8% after 10 minutes (Figure 4.1B), 
consistent with a role for cholesterol-dependent plasma membrane structure in this 
process. A previous study indicated that inhibition of SOCE by cholesterol depletion 
is due to depolarization of the plasma membrane (DeHaven 2009). To address this 
possibility, we evaluated the effect of high K+-mediated depolarization on the Ca2+ 
response to thapsigargin in cells treated with MβCD and in control cells. We found  
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Figure 4.1: Thapsigargin-stimulated SOCE and STIM1-Orai1 FRET following 
cholesterol depletion and PI4K inhibition. A) Representative Ca2+ responses as 
measured by indo-1 fluorescence in control RBL-2H3 cells (black circles), and cells 
treated with 4 mM MβCD for 20 min (red circles). Sensitivity to 1 µM Gd3+ is shown 
by addition at the indicated time points. B) Effect of cholesterol depletion on 
thapsigargin-stimulated FRET between AcGFP-Orai1 and STIM1-mRFP. Cells were 
untreated (black) or incubated with 5 mM MβCD for 10 min (red) prior to stimulation 
by thapsigargin. Error bars show SEM. C) Representative Ca2+ responses in control 
RBL-2H3 cells (black), and cells treated with 10 µM wortmannin for 10 min (green) 
prior to stimulation by thapsigargin. D) Thapsigargin-stimulated FRET between 
AcGFP-Orai1 and STIM1-mRFP in unperturbed cells (black) and cells treated with 10 
µM wortmannin (green). Error bars show SEM. 
 87 
that the MβCD-inhibited Ca2+ response remains sensitive to depolarization to a similar 
extent as the untreated control cells (Figure D.1). 
 Broad et al.  (2001) reported that inhibition of PI4P synthesis by 10-20 µM 
wortmannin causes substantial inhibition of ICRAC in RBL mast cells, providing 
evidence for a role for phosphoinositides in SOCE. Consistent with these results, we 
find that treatment of RBL cells with 10 µM wortmannin for 10 min at 37°C inhibits 
thapsigargin-stimulated Ca2+ entry by ~40% when assessed 5 min after addition of 
thapsigargin (Fig. 1C). To investigate the mechanism of this inhibition, we examined 
the effect of wortmannin on stimulated FRET under similar conditions. As shown in 
Figure 4.1D, we find that thapsigargin-stimulated FRET between AcGFP-Orai1 and 
STIM1-mRFP is inhibited 52 ± 8% by 10 µM wortmannin after 10 min of stimulation. 
This is consistent with reports that wortmannin and other PI4K inhibitors prevent 
colocalization of STIM1 and Orai1 in ER-plasma membrane puncta (Korzeniowski 
2009, Walsh 2010). Our results provide evidence that stimulated coupling between 
STIM1 and Orai1 depends on PI4P, either directly or because of it role as a precursor 
for other phosphoinositide species. 
 
4.4.2 PI5KIβ and PI5KIγ differentially modulate stimulated association of 
STIM1 with Orai1. 
 
In a recent study, our laboratory found that two related phosphatidylinositol 5’ 
kinases, PI5KIβ and PI5KIγ, synthesize functionally distinguishable pools of PIP2 that 
differentially affect antigen-stimulated SOCE (Vasudevan 2009). To investigate roles 
for PIP2 synthesis by these PIP5K isoforms in STIM1-Orai1 interactions, we 
monitored stimulated FRET between AcGFP-Orai1 and STIM1-mRFP in cells 
overexpressing either PI5KIβ or PI5KIγ. As shown in Figure 4.2A, we found that 
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overexpression of the Iβ isoform consistently enhances thapsigargin-stimulated 
association between STIM1-mRFP and AcGFP-Orai1, whereas overexpression of the 
PI5KIγ isoform consistently inhibits this interaction (Figure 4.2A).  
This differential modulation of STIM1-Orai1 association by two isoforms of PI5-
kinase that both produce PI-4,5-bisphosphate implies that each isoform must produce 
a distinguishable pool of PIP2. Previous studies utilized sucrose gradients to separate 
detergent-resistant membranes (DRM) from membrane proteins and lipids that are 
solubilized (DSM). This biochemical separation has proven useful for characterizing 
subregions of the plasma membrane that are distinguished by their composition of 
lipids with ordered (DRM) vs disordered (DSM) acyl chains (Brown 1992, Sheets 
1999, Simons 2000, Brown recent review).  In other studies, this approach provided 
evidence for two distinguishable pools of PIP2 that are differentially altered by EGF-
stimulated phospholipase C activation (Casey 1998). To test the possibility that 
PIP5KIβ and Iγ synthesize pools of PIP2 that preferentially associate with either 
ordered or disordered lipid pools, we compared the relative concentrations of PIP2 that 
fractionated with DRM and DSM from cells with and without overexpression of 
PI5KIβ and PI5KIγ. As summarized in Figure 4.2B, overexpression of both enzymes 
enhances total PIP2 in RBL cells, but PI5KIγ selectively enhances PIP2 in the DSM 
fraction, whereas PI5KIβ enhances PIP2 in both DRM and DSM pools. These results 
suggest that the enhancing effect of PIP5KIβ overexpression on stimulated 
STIM1/Orai1 association correlates most strongly with an increase in PIP2 in ordered 
lipid subregions, whereas the negative effect of PIP5KIγ on stimulated STIM1-Orai1 
interactions correlates with a selective increase in PIP2 in disordered lipid subregions.  
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Figure 4.2: Differential effects of PI5KI isoform overexpression on thapsigargin-
stimulated association between  AcGFP-Orai1 and STIM1-mRFP and PIP2 
concentrations. A) Stimulated FRET between STIM1 and Orai1 in control cells 
(black), cells co-expressing PI5KIβ (cyan), and cells co-expressing PI5KIγ (red).. 
Error bars show SEM. B) PI5KI isoforms differentially enhance PIP2 levels in DRMs 
and DSMs. Values are normalized to total PIP2 levels in control cells from each 
experiment. Error bars show SD. Unpaired, one-tailed Student’s t-test between 
indicated populations: * p = 0.03, ** p= 0.05, *** p = 0.05, n=3. 
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4.4.3 Depletion of PIP2 from the DRM membrane pool inhibits the 
thapsigargin-stimulated association of STIM1 and Orai1. 
 
To further evalutate  different roles of PIP2 in DRM and DSM pools on STIM1-Orai1 
association, we measured the thapsigargin mediated FRET between STIM1 and Orai1 
in RBL cells expressing PIP2 phosphatases that are selectively targeted to membrane 
subregions. Phosphatase, L10-Inp54p targets ordered lipid regions (DRM), and 
Phosphatase, S15-Inp54p targets disordered regions (DSM), as characterized 
previously by Johnson et al., (2008). As shown in Figure 4.3A, co-expression of L10-
Inp54p with AcGFP-Orai1 and STIM1-mRFP results in substantial inhibiton of 
thapsigargin-stimulated association of these proteins detected by FRET. In contrast, 
co-expression of S15-Inp54p with these reporter constructs results in a small increase 
in thapsigargin-stimulated FRET. As expected from previous results (Johnson 2008), 
we found that L10-Inp54p significantly depleted the levels of PIP2 in DRMs, but it did 
not significantly reduce the pool of DSM-associated PIP2 (Figure 4.3B). Also 
consistent with expectations, S15-Inp54p caused some reduction in the pool of DSM-
associated PIP2, but did not significantly reduce the pool of DRM-associated PIP2. 
These results are consistent with the trends observed for overexpression of PIP5KIβ 
and Iγ, and they indicate that PIP2 in ordered lipid regions promotes stimulated Orai1-
STIM1 association, whereas PIP2 in disordered lipid  regions inhibits this association. 
 
 91 
  
 
Time (min)
-5 0 5 10 15
F
R
E
T
-0.02
0.00
0.02
0.04
0.06
0.08
0.10
0.12
TG
P
IP
2
 c
o
n
c
e
n
tr
a
ti
o
n
 (
n
o
rm
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
wt
DRM fraction
L10-Inp54p
DRM fraction
L10-Inp54p
DSM fraction
S15-Inp54p
DRM fraction
S15-Inp54p
DSM fraction
wt
DSM fraction
A
B
*
*
**
**
 
Figure 4.3: Differential effects of targeted PIP2 phosphatase expression on 
thapsigargin-stimulated association between AcGFP-Orai1 and STIM1-mRFP 
and PIP2 concentrations. A) Stimulated FRET between STIM1 and Orai1 in 
unperturbed cells (black), cells coexpressing the DRM-targeted PIP2 phosphatase L10-
Inp54p (green), and cells coexpressing the DSM-targeted PIP2 phosphatase S15-
Inp54p (pink). Error bars show SEM. B) Targeted PIP2 phosphases selectively 
hydrolyze PIP2. Values are normalized to the total PIP2 from control cells for each 
experiment. Error bars show SD. Unpaired, one-tailed Student’s t-test between 
indicated populations: * p = 0.001, ** p = 0.007; n = 6. 
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4.4.4 Polybasic sequences in STIM1 and Orai1 are determinants of the 
dependence of the STIM1-Orai1 interaction on PIP2 in membrane 
subregions. 
 
The polylysine sequence at the C-terminus STIM1 (a.a. 677-685) has been shown to 
mediate puncta formation by STIM1 in the plasma membrane puncta in the absence of 
Orai1 overexpression, but it is not necessary for this puncta formation in the presence 
of co-expressed Orai1 (Park 2009; Walsh 2009). When we deleted this basic sequence 
from STIM1-mRFP (STIM1∆K-mRFP), we observed a modest enhancement in the 
kinetics of thapsigargin-stimulated FRET between this mutant protein and AcGFP-
Orai1 compared with that for wtSTIM1-mRFP. However, the extent of this interaction 
was similar at longer time points to that seen between wild type STIM1-mRFP and 
AcGFP-Orai1 in the absence of PIP2 perturbation (Figure 4.4A, black curve). Co-
expression of S15-Inp54p with STIM1∆K-mRFP and AcGFP-Orai1 did not 
significantly alter the magnitude or the kinetics of the stimulated interaction (Figure 
4.4A, pink curve). In contrast, although the interaction between wild type STIM1-
mRFP and AcGFP-Orai1 is substantially inhibited by co-expression of L10-Inp54p 
(Figure 4.4A, dark green curve), the interaction between STIM1∆K-mRFP and 
AcGFP-Orai1 is slightly enhanced under these conditions (Figure 4.4A, green curve). 
These results suggest that the C-terminal polybasic sequence of STIM1 contributes a 
positive role in STIM1/Orai1 association by interacting with the ordered lipid pool of 
PIP2. In the absence of this basic sequence, this pool of PIP2 is not necessary for 
stimulated STIM1-Orai1 association. 
When we examined the effect of PIP5KIβ overexpression on the stimulated 
association of STIM1∆K-mRFP and AcGFP-Orai1, we found this to be similar but 
slightly slower than the same interaction in control cells (Figure 4.4B, cyan curve).  
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Figure 4.4: The stimulated association between STIM1∆K and Orai1 does not 
exhibit PIP2 pool selectivity. A) The thapsigargin-stimulated FRET between AcGFP-
Orai1 and STIM1∆K-mRFP in control cells (black), cells expressing L10-Inp54p 
(light green), and cells expressing S15-Inp54p (pink). Note that the inhibition of the 
interaction between wild type STIM1 and Orai1 in the presence of L10-Inp54p (dark 
green, from Fig. 4.3A) is lost with the STIM1∆K mutant. B) The thapsigargin 
stimulated FRET between AcGFP-Orai1 and STIM1∆K-mRFP in control cells 
(black), cells expressing PI5KIβ (cyan) and cells expressing PI5KIγ (light red). Note 
that the inhibition of the interaction between wild type STIM1 and Orai1 in the 
presence of PI5KIγ (dark red, from Fig. 4.2A) and the enhancement of the interaction 
in the presence of PI5KIβ (not reproduced) are lost with the STIM1∆K mutant. Error 
bars show SEM. 
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Thus, the enhancing effect of PIP5KIβ on the association of wildtype proteins is not 
observed with STIM1∆K-mRFP. As above, this is consistent with a positive role for 
an interaction between the STIM1 C-terminal polybasic sequence and PIP2 in ordered 
lipid subregions of the membranein promoting STIM1-Orai1 association. In contrast, 
overexpression of PI5KIγ, which inhibits wildtype STIM1-Orai1 interactions, does not 
inhibit the association between STIM1∆K-mRFP and AcGFP-Orai1 (Figure 4.4B, 
compare dark red curve to red curve). This result is consistent with a negative 
regulatory interaction between the disordered lipid pool of PIP2 and the C-terminal 
polybasic sequence of STIM1. Note that although PIP5KIβ overexpression also 
increases the disordered lipid pool of PIP2, this effect is compensated by the increase 
in PIP2 in ordered lipid regions that it causes. 
Orai1 has a polybasic sequence composed primarily of arginine residues near 
its N-terminus, (a.a 28-33). When this sequence is removed (AcGFP-Orai1∆R), this 
mutant Orai1 localizes normally to the plasma membrane (Figure D.2), and stimulated 
FRET between AcGFP-Orai1∆R and STIM1-mRFP is similar to that for the wildtype 
proteins (Figure 4.5A, black curve). Also similar to the wildtype proteins, stimulated 
FRET between AcGFP-Orai1∆R and STIM1-mRFP is significantly reduced in cells 
expressing L10-Inp54p (Figure 4.5A, green curve). This indicates that the 
polyarginine sequence in Orai1 is not involved in the sensitivity of STIM1/Orai1 
association to depletion of the ordered lipid pool of PIP2. In contrast, stimulated 
association of STIM1-mRFP and AcGFP-Orai1∆R is significantly inhibited after 
depletion of the disordered lipid pool of PIP2 by S15-Inp54p, even though it is 
enhanced for wildtype STIM1 and Orai1 under these conditions (Figure 4.5A, 
compare purple curve to pink curve). These results indicate that this basic sequence in 
Orai1 contributes to positive regulation of STIM1-Orai1 association that involves the 
disordered lipid pool of PIP2. 
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Figure 4.5: The interaction between STIM1 and Orai1∆R has altered PIP2 pool 
selectivity. A) Thapsigargin-stimulated FRET between AcGFP-Orai1∆R and STIM1-
mRFP in control cells (black), cells expressing L10-Inp54p (light green), and cells 
expressing S15-Inp54p (pink). Note that the enhancement of the interaction between 
STIM1 and wild type Orai1 in the presence of S15-Inp54p (purple, from Fig. 4.3A) is 
replaced by inhibition with the Orai1∆R mutant. B) Thapsigargin-stimulated FRET 
between AcGFP-Orai1∆R and STIM1-mRFP in control cells (black), cells expressing 
PI5KIβ (cyan) and cells expressing PI5KIγ (red). Note that the enhancement of the 
interaction between STIM1 and wild type Orai1 in the presence of PI5KIβ (blue, from 
Fig. 4.2A) is lost with the Orai1∆R mutant. Error bars show SEM. 
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 Deletion of the polyarginine sequence near the N-terminus of Orai1 also alters 
the effect of overexpressing PI5KIβ on the STIM1-Orai1 association. For the wild-
type proteins, this stimulated association is enhanced by overexpression of PI5KIβ, 
but for STIM1-mRFP and AcGFP-Orai1∆R this association is reduced (Figure 4.5B, 
compare dark blue curve to cyan curve). In contrast, overexpression of PI5KIγ 
similarly affects stimulated FRET between STIM1-mRFP and either AcGFP-Orai1∆R 
or wildtype AcGFP-Orai1, causing modest inhibition in both cases (Figure 4.5B, red 
curve). These results indicate that the basic polyarginine sequence at the N-terminus of  
Orai1 is important for the enhancing effect of PI5KIβ, but not for the inhibitory effect 
of PIP5KIγ. They can be accounted by a mechanism in which this basic sequence 
promotes the association of STIM1 with Orai1 by interacting with the ordered lipid 
pool of PIP2. 
 
4.4.5 Segregation of Orai1 into ordered lipid and disordered lipid subregions of 
the plasma membrane is dynamically controlled by the distribution of 
PIP2 between these subregions. 
 
When unstimulated cells overexpressing STIM1-mRFP and AcGFP-Orai1 are 
solublized with TX-100 and separated by sucrose gradient fractionation, most AcGFP-
Orai1 fractionates with DSM (disordered lipids) when detected with anti-GFP mAb 
(Figure 4.6). However, when PIP2 from the DSM fraction is depleted by coexpression 
of S15-Inp54p, a larger percentage of Orai1 is found in the DRM (ordered lipids) 
fraction. Conversely, the percentage of Orai1 that fractionates with DRMs decreases 
when PIP2 in this fraction is preferentially depleted by L10-Inp54p. These results 
provide evidence that although Orai1 primarily resides in disordered lipid subregions 
in unstimulated cells, its relative concentration in the ordered vs disorded lipid  
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Figure 4.6: Localization of Orai1 to DRM or DSM fractions depends on the 
presence of PIP2. Comparative distribution of AcGFP-Orai1 in DRM and DSM 
fractions determined by sucrose gradient fractionation. Depletion of PIP2 from the 
DRM fraction with L10-Inp54p decreases the relative portion of Orai1 in the DRM 
fraction, whereas depletion of PIP2 from the DSM fraction with S15-Inp54p increases 
the relative portion of Orai1 in the DRM fraction. 
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subregions depends on the concentration of PIP2 in the respective pools. 
 
4.5 Discussion 
 
4.5.1 Thapsigargin mediated STIM1-Orai1 association is inhibited by PIP2 in 
the disordered lipid subregions of the membrane and enhanced by PIP2 in 
the ordered lipid subregions. 
 
Our results support roles for cholesterol-dependent membrane heterogeneity and for 
segregated pools of phosphoinositides in the stimulated association of STIM1 with 
Orai1. Initial experiments revealed that depletion of cholesterol inhibits thapsigargin-
stimulated association between donor-labeled Orai1 and acceptor-labeled STIM1 in 
parallel with the inhibition of SOCE (Figure 4.1A,B). Similarly, inhibition of PI4P 
synthesis by 10 µM wortmannin inhibits stimulated FRET between these labeled 
proteins (Figure 4.1C,D). These results, together with those from Vasudevan et al. 
(2009), led us to the hypothesis that PIP2 synthesized by two different isoforms of 
PI5K is segregated in two different membrane domains. Although proteins are clearly 
involved, these domains arise in part by cholesterol-based ordering of lipids and are 
simply categorized as ordered lipid and disordered lipid subregions. To test this 
hypothesis, we evaluated the effects of PI5KIβ and Iγ overexpression on stimulated 
association between STIM1 and Orai1 as measured by FRET, and we compared these 
effects to alterations in PIP2 levels in DRM (ordered lipids) and DSM (disordered 
lipids) fractions caused by these kinases. An increase in stimulated FRET due to 
overexpression of PI5KIβ correlated with an increase in PIP2 in both DRM and DSM 
fractions, whereas a decrease in stimulated FRET caused by PI5KIγ correlated with a 
selective increase in PIP2 in the DSM fraction (Figure 4.1). To directly reduce PIP2 
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levels in either ordered lipid or disordered lipid subregions, we used respectively 
targeted inositol 5-phosphatases. We found that these resulted in changes in stimulated 
FRET that are consistent with consistent with PI5KIβ and Iγ overexpression, i.e. 
reduction in PIP2 in ordered lipid pools inhibits stimulated FRET, whereas reduction 
in PIP2 in disordered lipid pools enhances stimulated FRET. 
Thus, a consistent result from our data is that the interaction between STIM1-
mRFP and AcGFP-Orai1 is inhibited under conditions where there is a greater 
proportion of PIP2 in disordered lipid subregions of the membrane than PIP2 in 
ordered lipid subregions. This  disproportionality can be generated by either 
hydrolysis of PIP2 in ordered lipid subregions by targeted L10-Inp54p or when the 
pool of  PIP2 in disordered lipid subregions is enhanced by PI5KIγ. This consistent 
symmetry between the effects of PIP2 distributed between ordered lipid and disordered 
lipid subregionsis is accompanied by an apparent insensitivity to the total amount of 
PIP2 present in the membrane.. This pattern is consistent with previous reports that 
found little effect on Ca2+ mobilization or punctae formation without complete 
removal of PIP2 from the plasma membrane (Korzeniowski  2009, Walsh 2010).These 
previous reports did not consider a differential effect of multiple pools of PIP2, and did 
not use a direct measurement of the association between the two proteins. 
 
4.5.2 The polybasic sequences on STIM1 and Orai1 confer the selectivity of 
DRM and DSM pools of PIP2 to the STIM1-Orai1 interaction 
 
When we removed either the C-terminal polylysine sequence from STIM1 or the N-
terminal polyarginine sequence from Orai1,, the selectivity of the STIM1-Orai1 
interaction for a particular pool of PIP2 was largely lost, i.e. FRET between STIM1 
and Orai1 constructs was similar for cells overexpresing L10-Inp54p and S15-Inp54p,  
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Figure 4.7: Proposed scheme for the PIP2 dependent association of STIM1 and 
Orai1. A) In cells coexpressing the wild type proteins STIM1 and Orai1, SOCE is 
initiated by the translocation of STIM1 to DRM associated PIP2 (ER membrane 
omitted for clarity). This is followed by the PIP2 dependent equilibration of Orai1 
between DRM and DSM fractions, to form the productive interaction with STIM1 in 
the DRM fraction. The equibration of Orai1 between membrane pools conferes the 
differential selectivity of the interaction to PIP2 in the DRM and DSM pools. B) In 
cells expressing STIM1∆K and wild type Orai1, STIM1 lacks the polylysine sequence 
directing it to interact with PIP2, allowing STIM1 to engage Orai1 directly, without an 
intermediate PIP2 binding step. PIP2 pool selectivity is lost because productive 
interactions can be formed in both membrane fractions. C) In cells expressing wild 
type STIM1 and Orai1∆R, Orai1 lacks the PIP2 mediated redistribution between 
membrane pools. We predict that the productive interaction between STIM1 and 
Orai1∆R most likely occurs in the DRM membrane fraction, but the redistribution of 
Orai1 into this fraction is no longer PIP2 dependent. 
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or PI5KIβ and PI5KIγ. However, this selectivity was lost in very different ways for the 
two proteins. When the polylysine sequence from STIM1 was deleted, the FRET 
between STIM1∆K-mRFP and AcGFP-Orai1 was as high or higher than the FRET 
between the wild-type proteins in every case (Figure 4.4). In contrast, the deletion of 
the N-terminal polyarginine sequence of Orai1, caused the FRET between STIM1-
mRFP and AcGFP-Orai1∆R to be as low or lower than every case involving the wild-
type proteins (Figure 4.5). Nevertheless, in both cases, sensitivity to depletion or 
enhancement of a particular pool of PIP2 was eliminated. These results are consistent 
with our model described below, in which wild-type proteins utilize both PIP2-
mediated translocation of Orai1 from disordered to ordered lipid pools and 
thapsigargin-stimulated association of STIM1 with PIP2 in ordered lipid subregions.  
The differences between removal of the polybasic sequences from STIM1 and 
Orai1may be accounted for by their competition with endogenous, wild-type 
counterparts. Removal of the polylysine sequence on STIM1 may allow its free 
engagement with Orai1 associated with either ordered or disordered lipid pools. This 
is consistent with previous results showing that, although the polylysine sequence on 
STIM1 is important for translocation to the plasma membrane in the absence of Orai1, 
interaction with Orai1 is sufficient to concentrate STIM1 into ER-plasma membrane 
punctae (Park 2009). The modest enhancement of the interaction between STIM1∆K-
mRFP and AcGFP-Orai1 seen at long time points, when the ordered lipid pool of PIP2 
is depleted by L10-Inp54p, may occur because inhibition of the interaction between 
endogenous, wild-type STIM1 and overexpressed AcGFP-Orai1 is reduced under 
these conditions, thereby freeing a larger pool of AcGFP-Orai1 to interact with the 
mutant STIM1∆K-mRFP. 
Conversely, removal of the polyarginine sequence of Orai1 appears to 
substantially limit its interaction with STIM1 following perturbation of the PIP2 
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distribution. In particular, FRET between STIM1-mRFP and AcGFP-Orai1∆R is the 
lowest when S15-Inp54p is expressed, despite being strong for the labeled wild-type 
proteins (Figure 4.5A). Similar to the situation in which STIM1∆K-mRFP must 
compete with endogentous STIM1, AcGFP-Orai1∆R may compete less efficiently 
with endogenous Orai1 for association with STIM1. 
 
4.5.3 The thapsigargin mediated STIM1-Orai1 interaction requires the PIP2 
mediated translocation of Orai from disordered lipid subregions to 
ordered lipid subregions of the membrane 
 
A simplistic model that accounts for all of our observations is summarized in Figure 
4.7. It posits that the the STIM1 C-terminal polylysine sequence targets STIM1 to 
PIP2 in ordered lipid subregions after stimulation by thapsigargin. The N-terminal 
polyarginine sequence of Orai1 contributes to its localization with disordered lipids in 
the resting state via its interaction with PIP2 in those subregions. With stimulation, this 
model, Orai1 translocates to the ordered lipid subregions to engage STIM1.Thus the 
relative distribution of PIP2 in the ordered lipid and disordered lipid subregions 
influences the propensity of Orai1 to redistribute into the ordered lipid subregions 
where it can engage STIM1. In a previous study, STIM1 from cell lysates was shown 
to fractionate with DRMs in sucrose gradients in a strongly thapsigargin dependent 
manner (Pani 2008). As shown in Figure 4.6, Orai1 fractionates largely with DSM in 
unstimulated cells, and this preference is reduced in S15-Inp54p-expressing cells. In 
cases were the proportion of PIP2 in DSM is high (such as with coexpression of L10-
Inp54p or PI5KIγ), Orai1 has a reduced propensity both to redistribute into the DRM 
pool and and to associate with STIM1 as measured by FRET. This model is consistent 
with our western blotting data showing that the distribution of Orai1 between DRM 
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and DSM fractions parallels the relative fraction of PIP2 fractionating in these two 
pools (Figure 4.6). It is also consistent with our observations that removal of the 
polybasic targeting sequence ineither STIM1 or Orai1 interferes with the sensitivity of 
the STIM1/Orai1 to conditions of high PIP2 levels in the ordered lipid pool, albeit by 
the different mechanisms described above. 
Removal of polybasic sequences in the N-terminus of Orai1 or the C-terminus 
of STIM1 alters the mode of interaction between these two proteins. Removal of the 
polylysine sequence on STIM1 (Figure 4.7B) prevents the initial association of 
STIM1∆K with the ordered lipid pool of PIP2, but does not prevent the direct 
association of STIM1∆K with Orai1 as measured by FRET (Figure 4.7B). This 
scheme is consistent with previous reports that characterized Orai1 dependent and 
independent modes of STIM1 association with the plasma membrane following 
thapsigargin mediated store depletion, and that identified the polylysine sequence on 
STIM1 as important for the Orai1-independent mode of association (Park 2009). The 
loss of PIP2 selectivity in this case is due to the loss of stimulated association of 
STIM1∆K with ordered lipid subregions in the membrane, thereby allowing 
STIM1∆K to engage Orai1 in either the ordered or disordered lipid subregions. This 
mutation generally  increases the association between STIM1∆K and Orai1 and can be 
explained by the capacity of STIM1∆K to engage Orai1 without restrictions imposed 
by PIP2 in membrane subregions. 
 We also find that the removal of the polyarginine sequence on the N-terminus 
of Orai1 results in the loss of PIP2 sensitivity, but this may not affect,  the capacity of 
STIM1 to bind to PIP2 in ordered lipid subregions or the capacity of Orai1 to diffuse 
into these subregions to engage STIM1. Removal of the polyarginine sequence causes 
Orai1 to fractionate with both DRM and DSM lipid pools in a PIP2- independent 
fashion, corresponding to a loss of selectivity for PIP2 in one subregion over the other. 
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In this case, the redistribution of Orai1 between lipid subregions  may depend more on 
the intrinsic partitioning of Orai1 between ordered vs disordered lipid subregions, 
rather than on interactions with PIP2 in these pools. 
The present model cannot fully account for more subtle, quantitative 
relationships between PIP2 localized to ordered lipid subregions or disordered lipid 
subregions of the membrane. For example, there is significant increase in the 
interaction between STIM1-mRFP and AcGFP-Orai1 following overexpression of 
PI5KIβ, which also causes an increase in PIP2 that fractionate with both DRM and 
DSM. This result could be explained if enhancement of the STIM1-Orai1 interaction 
by PIP2 in ordered lipid subregions is more potent than the inhibition by the PIP2 in 
disordered subregions, but current data are insufficient to evaluate this posibility. In 
future experiments, the extent to which the regulation of PIP2 levels in subregions of 
the membrane influences stimulated SOCE will need to be investigated systematically. 
Especially in the case of physiological stimulation by antigen, the balance between 
PIP2 in distinctive subregions may be particularly important in regulating the 
functional outcome. 
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CHAPTER 5 
FUTURE DIRECTIONS 
 
5.1 Further investigations of the molecular basis of the STIM1-Orai1 
interaction. 
 
Using an electrostatic protein interaction model, we have identified four regions on 
STIM1 and Orai1 necessary for their interaction. On Orai1 we identified a C-terminal 
acidic coiled-coil important for clustering (chapter 2) and gating of Ca2+ influx 
(chapter 3). Additionally, in chapter 3 we identify the intermolecular binding partner 
for this region on STIM1, a short basic sequence in the CAD domain. Finally, in 
chapter 4 we identified polybasic sequences on both STIM1 and Orai1 important for 
their interaction with phosphoinositides at the plasma membrane. All of these 
sequences were identified using a simple structural model for protein surface charge 
density. In short, secondary structure is estimated using the periodicity of the 
sidechain hydrophobicity. Using this estimate, we identify structural elements of the 
protein with high positive or negative charge density. Once these regions are 
identified, any potential intramolecular charge-charge interactions are ruled out by 
examining the periodicity of the longitudinal charge density: Our assumption is that 
regions of alternating charge density are forming intramolecular interactions. Regions 
of higher charge density are assumed to have a longer periodicity if involved in long 
range intramolecular interactions. Any sequences that remain unpaired to 
intramolecular binding partners are considered important for intermolecular 
interactions. Using this technique, several other sequences in STIM1 and Orai1 were 
identified besides those that were investigated in this dissertation. Two regions of 
immediate interest on STIM1 are a stretch of glutamates in the CAD region (a.a. 318-
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322), and a heptad of acid amino acids in the serine/praline rich domain (a.a. 475-483) 
(Figure 5.1). Also of interest is the juxtamembrane polybasic region immediately N-
terminal to the first transmembrane region of Orai1 (a.a. 79-93). Although the function 
of these regions is unknown, the efficacy of this approach has been demonstrated for 
others in our previous studies. 
 
5.2 The orchestrated movement of STIM1 and Orai1 at the plasma 
membrane. 
 
In chapter 4, we outlined a scheme by which STIM1 translocates to pool of PIP2 
localized in ordered lipid subregions of ER-plasma membrane junctions, and Orai1 
redistributes between the  PIP2 in disordered lipid ordered lipid subregions to engage 
STIM1. This scheme accounts for all the observations in chapter 4, but has not been 
directly tested. Therefore, we propose a study to quantify the distribution of STIM1 
and Orai1 that fractionate with DRM (ordered lipids) and DSM (disordered lipids) 
following thapsigargin stimulation. Figure 4.6 shows some dependence of the 
distribution of Orai1 in DRM and DSM fractions on the concentration of PIP2 in these 
fractions. To investigate further the movement of these proteins between lipid pools, 
we can similarly monitor the distribution of both STIM1 and Orai1 in DRM and DSM 
fractions following stimulation. To test the hypothesis that the polybasic sequences on 
STIM1 and Orai1 direct their movement between ordered and disordered lipid pools, 
these results can be compared to the distributions of STIM1 and Orai1 mutants lacking 
these sequences. Fusions of these polybasic sequences to fluorescent proteins could 
further help us evaluate whether these sequences alone are sufficient to direct this 
behavior, by allowing the direct observation of these membrane dynamics, either in 
model systems or in cells.
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Figure 5.1: Primary sequence analysis of Orai1 and STIM1. Using the electrostratic 
protein interaction prediction technique described in section 5.1, we have identified 
the above highlighted sequences as of interest. The sequences highlighted in blue have 
already been investigated in the preceding chapters and have all been found to be 
important for the STIM1-Orai1 interaction. The sequences highlighted in red have not 
been investigated and are of unknown function. 
Orai1 Sequence 
MHPEPAPPPSRSSPELPPSGGSTTSGSRRSRRRSGDGEPPGAPPPPPSAVTYPDWIG 
QSYSEVMSLNEHSMQALSWRKLYLSRAKLKASSRTSALLSGFAMVAMVEVQLDADHD 
YPPGLLIAFSACTTVLVAVHLFALMISTCILPNIEAVSNVHNLNSVKESPHERMHRH 
IELAWAFST VIGTLLFLAEVVLLCWVKFLPLKKQPGQPRPTSKPPASGAAANVSTS 
GITPGQAAAIASTTIMVPFGLIFIVFAVHFYRSLVSHKTDRQFQELNELAEFARLQD 
QLDHRGDHPLTPGSHYA 
MDVCVRLALWLLWGLLLHQGQSLSHSHSEKATGTSSGANSEESTAAEFCRIDKPLCH 
SEDEKLSFEAVRNIHKLMDDDANGDVDVEESDEFLREDLNYHDPTVKHSTFHGEDKL 
ISVEDLWKAWKSSEVYNWTVDEVVQWLITYVELPQYEETFRKLQLSGHAMPRLAVTN 
TTMTGTVLKMTDRSHRQKLQLKALDTVLFGPPLLTRHNHLKDFMLVVSIVIGVGGCW 
FAYIQNRYSKEHMKKMMKDLEGLHRAEQSLHDLQERLHKAQEEHRTVEVEKVHLEKK 
LRDEINLAKQEAQRLKELREGTENERSRQKYAEEELEQVREALRKAEKELESHSSWY 
APEALQKWLQLTHEVEVQYYNIKKQNAEKQLLVAKEGAEKIKKKRNTLFGTFHVAHS 
SSLDDVDHKILTAKQALSEVTAALRERLHRWQQIEILCGFQIVNNPGIHSLVAALNI 
DPSWMGSTRPNPAHFIMTDDVDDMDEEIVSPLSMQSPSLQSSVRQRLTEPQHGLGSQ 
RDLTHSDSESSLHMSDRQRVAPKPPQMSRAADEALNAMTSNGSHRLIEGVHPGSLVE 
KLPDSPALAKKALLALNHGLDKAHSLMELSPSAPPGGSPHLDSSRSHSPSSPDPDTP 
SPVGDSRALQASRNTRIPHLAGKKAVAEEDNGSIGEETDSSPGRKKFPLKIFKKPLK 
K  
STIM1 Sequence 
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5.3 The biophysical basis of PIP2 phase selectivity. 
 
As outlined in chapter 4, the phosphatidylinositol kinase PI5KIγ generates PIP2 
primarily associated with the disordered lipid pool, whereas PI5KIβ produces PIP2 
associated with both ordered and disordered lipid pools. Although we can 
reproducibly observe the effects of modulating these pools, the mechanism by which 
these pools are maintained is unclear. One explanation that can account for this 
selectivity is that the PIP2 in the ordered lipid pool  is chemically distinct from the 
PIP2 in the disordered lipid pool. The acyl chain saturation of different PIP2 species 
could direct their concentration into a particular lipid pool. Proteins could differentiate 
between PIP2 pools either by the direct recognition of the acylation of a particular PIP2 
species or by recognizing the surrounding lipid domain. This explanation is attractive 
because it does not require inhibiting the diffusion of PIP2 in a particular pool as long 
as the partition coefficients for different PIP2 species are sufficiently different. Wenk, 
et al., however, found that the vast majority of PIP2 in the cell contains acyl chains 
with 38 carbons and 4 double bonds, total. This result would suggest that the majority 
of PIP2 should reside in the disordered lipid subregions. However, in the results 
presented in chapter 4, we find that there is an approximately equal fractionation of 
PIP2 with DRM and DSM. To understand the contribution of varying acylation on 
PIP2 phase selectivity, we have begun a collaboration with Catherine Costello at 
Boston University School of Medicine to quantify the PIP2 species extracted from 
DRM and DSM fractions under different perturbations and stimulatory conditions. 
 A separate mechanism that could contribute to the maintenance of PIP2 pools 
is that the association with proteins or other molecules at the plasma membrane could 
maintating the concentration of PIP2 into subregion. In chapter 1, we outlined an array 
of proteins that bind or crosslink PIP2 at the plasma membrane. The lateral 
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organization of PIP2 induced by association with polybasic peptides could drive its 
association with a particular subregion. We have found that overexpression of the 
MARCKS effector domain enhances the pool of PIP2 associated with the DSM lipid 
fraction (data not shown), while others have demonstrated that GAP-43 drives 
association of PIP2 with the DRM lipid fraction (Tong 2008). In chapter 4, we 
describe a model where the oligomerization of STIM1 drives the selective association 
of its C-terminal polylysine sequence with PIP2 in the ordered lipid subregion. As 
described in chapter 2, we have found that small molecules such as spermine or D-
sphingosine that change the electrostatics at the plasma membrane also inhibit the 
STIM1-Orai1 interaction, posing the possibility that this inhibition is due to 
modulating the concentration of PIP2 in a particular pool. There are significant 
opportunities to expand our understanding of these processes, and understand how 
multiple pools of PIP2 are formed and  restricted to subregions the plasma membrane 
with functional consequences. For instance, in vitro studies of model membranes 
containing PIP2 could elucidate whether the MARCKS effector domain simply 
recognizes the PIP2 in disordered lipid subregions or whether it induces formation of 
these subregions. Similar studies could be performed on GAP-43, the STIM1 C-
terminus, or peptide libraries to identify the precise molecular determinants of domain 
selectivity. 
 
5.4 PIP2 selectivity in the antigen mediated STIM1-Orai1 interaction 
 
As outlined in chapter 4, we investigated the dependence of the thapsigargin 
stimulated STIM1-Orai1 interaction on DRM and DSM pools of PIP2. Absent from 
this analysis was an investigation of the dependence of the antigen stimulated STIM1-
Orai1 interaction on pools of PIP2 or an analysis of the effect of the PIP2 directing 
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sequences on STIM1 and Orai1 after antigen stimulation. There are two caveats 
associated with measuring the FRET between AcGFP-Orai1 and STIM1-mRFP 
following antigen stimulation: 1) Unlike with thapsigargin, antigen stimulation does 
not prevent store refilling, resulting in an attenuation of the STIM1-Orai1 interaction 
(chapter 2). 2) Antigen stimulation alters the PIP2 pools by hydrolysis of PIP2 to DAG 
and IP3. Due to these complications, interpreting the antigen stimulated FRET after 
PIP2 perturbation has been difficult. Moreover, the scheme presented in chapter 4 for 
the dependence of the interaction on PIP2 in ordered vs disordered lipid subregions is 
insufficient to explain the results associated with antigen stimulation. A thorough 
accounting of the concentration of PIP2 fractionating with DRM and DSM pools of 
lipid is required to understand the precise conditions under which the antigen 
stimulated STIM1-Orai1 interaction occurs. Additionally, high speed Ca2+ imaging 
can be employed to investigate the role of the feedback between Ca2+ and PIP2 in 
dictating the periodicity of Ca2+ oscillations in mast cells.
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APPENDIX A 
ANTIGEN-MEDIATED STIM1-ORAI1 ASSOCIATION 
 
A.1 Enhancement of plasma membrane PIP2 with PI5K increases the antigen 
mediated STIM1-Orai1 interaction 
 
Similar to cells stimulated with thapsigargin (Figure 4.2), we stimulated cells 
expressing either PI5KIβ or PI5KIγ with antigen and measured the FRET between 
AdGFP-Orai1 and STIM1-mRFP. We found that although there is very little 
interaction between STIM1 and Orai1 in unperturbed cells following antigen 
stimulation (Figure A.1, black), there is significant interaction between STIM1 and 
Orai1 when they are overexpressed in the presence of either PI5K isoform (Figure A.1 
cyan, red). The increase in FRET associated with stimulation is similar for both 
isoforms, although cells overexpressing PI5KIβ appear to have faster initial kinetics. 
The absolute degree of FRET after 10 minutes is similar to that seen when control 
cells are stimulated with thapsigargin (Figure 2.3). In contrast to thapsigargin 
stimulated cells, there appears to be no special selectivity for the degree of STIM1-
Orai1 interaction in cells expressing the PI5KIβ verses the PI5KIγ isoform. 
 
A.2 The antigen mediated STIM1-Orai1 interaction is sensitive to selective 
PIP2 depletion with targeted phosphatases 
 
In contrast to cells perturbed by PI5KI isoforms, the antigen mediated STIM1-Orai1 
shows special selectivity for PIP2 fractionating with DRM and DSM when these pools 
are selectively depleted using the PIP2 phosphatases, L10-Inp54p and S15-Inp54p, that 
  116 
target ordered lipid subregions and disordered lipd subregions of the membrane, 
respectively (described in chapter 4). Cells stimulated with antigen in the presence of 
overexpressed L10-Inp54p (Figure A.2, green) show a dramatic increase in the degree 
of FRET between AcGFP-Orai1 and STIM1-mRFP over unperturbed cells (Figure 
A.2, black), whereas there is only a very small enhancement of the interaction 
associated with overexpression of S15-Inp54p (Figure A.2, pink). This trend is the 
exact opposite than is seen for thapsigargin stimulated cells, where overexpression of 
L10-Inp54p is associated with inhibition of the interaction. This means that although 
the DRM pool of PIP2 is associated with enhancement of the thapsigargin mediated 
interaction, this same pool inhibits the antigen mediated interaction. 
 
A.3 Removal of the polybasic PIP2 directing sequences on STIM1 or Orai1 
removes the PIP2 pool selectivity for the antigen mediated interaction 
 
Similar to cells stimulated with thapsigargin, when either STIM1∆K-mRFP or 
AcGFP-Orai1∆R is paired with its wild type interaction partner, any major selectivity 
for PIP2 in ordered vs disordered lipid subregions is lost (Figures A.3, A.4). 
Specifically, removal of either polybasic sequence removes the enhancement of the 
interaction associated with overexpression of L10-Inp54p (green). However, there is a 
small but significant enhancement of the interaction between STIM1∆K and Orai1 
associated with depletion of DSM PIP2 with S15-Inp54p at long time points. Unlike 
thapsigargin-stimulated cells, both mutants are associated with a low level of STIM1- 
Orai1 association as measured by FRET, whereas cells expressing STIM1∆K-mRFP 
typically showed enhanced responses to thapsigargin (Figure 4.3). One potential 
explanation for this result is that the enhancement of the interaction between 
STIM1∆K and Orai1 following thapsigargin stimulation is contingent on the 
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Figure A.1: Antigen mediated FRET between AcGFP-Orai1 and STIM1-mRFP in 
the presence of PI5KI isoforms. The antigen mediated interaction between STIM1 
and Orai1 is enhanced when coexpressed with PI5KIβ (cyan) and PI5KIγ (red) when 
compared to unperturbed cells (black). Error bars show SEM. 
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Figure A.2:  The antigen mediated STIM1-Orai1 interaction is selectively 
perturbed by targeted phosphatases. The coexpression of the DRM targed PIP2 
phosphatase L10-Inp54p with AcGFP-Orai1 and STIM1-mRFP damatically enhances 
the interaction between the two proteins (green) in response to antigen, compared to 
unperturbed cells (black). There is also a small but significant increase the in the 
STIM1-Orai1 interaction associated with coexpression of the DSM targeted 
phosphatases S15-Inp54p (pink). The differential sensitivity to expression of L10-
Inp54p and S15-Inp54p suggests that the antigen mediated STIM1-Orai1 interaction is 
selective for DRM and DSM pools of PIP2. Error bars show SEM. 
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permanent depletion of Ca2+ stores. Based on these results using the polybasic deletion 
mutants, we can conclude that although the PIP2 pool selection is different for antigen 
mediated cells than thapsigargin mediated cells, this selectivity is still mediated by the 
polylysine sequence on STIM1 and the polyarginine sequence on Orai1. 
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Figure A.3: The antigen mediated interaction between STIM1∆K and Orai1 
shows altered PIP2 selectivity. Similar to the thapsigargin mediated interaction, 
(Figure 4.4A), removal of the STIM1 C-terminal polylysine sequence changes the 
selectivity of the STIM1-Orai1 interaction for DRM and DSM pools of PIP2. When 
compared to the pairing of wild type proteins (Figure A.2), removal of the polylysine 
sequence removes the enhancement of the interaction associated with coexpression of 
L10-Inp54p (green). There is also an increase in the STIM1∆K-Orai1 interaction 
associated with coexpression of S15-Inp54p at long time points (pink), and a transient 
increase in the STIM1∆K-Orai1 interaction immediately after addition of antigen in 
the absence of perturbation (black). Error bars show SEM. 
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Figure A.4: The antigen mediated interaction between STIM1 and Orai1∆R 
shows altered PIP2 selectivity.  The removal of the N-terminal polyarginine sequence 
of Orai1 results in low levels of FRET for all cases of perturbation. Although there is a 
small but significant enhancement of the interaction of STIM1 and Orai1∆R when 
unperturbed (black) compared to the STIM1-Orai1 interaction (Figure A.2), the degree 
of interaction in the presence of the DSM targeted PIP2 phosphatase S15-Inp54p 
(pink) was unchanged and the interaction in the presence of the DRM targeted 
phosphatase L10-Inp54p (green) was significantly attenuated. Error bars show SEM. 
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APPENDIX B 
SUPPLEMENT FOR CHAPTER 2 
 
B.1 Experimental 
 
B.1.1 Primers used for cloning 
STIM1-HA 5’ primer: 
5’-GCATTGAAGCTTGCCACCATGGATGTATGCGTC-3’ 
STIM1-HA 3’ primer: 
5’-
TGTCTGGCGGCCGCCTACGCATAATCCGGCACATCATACGGATACTTCTTA 
AGAGGCTTC-3’ 
STIM1-mRFP 5’ primer: 
5’-GCGATAGCGGCCGCATCAGGCATGGCCTCCTCCGAGGAC-3’ 
STIM1-mRFP 3’ primer: 
5’-AAGTTCCTCGAGTTAGGCGCCGGTGGAGTG-3’ 
STIM1 5' Flanking (For eYFP-STIM1) 
5’- GATTTCCAAGTCTCCACCCCATTGAC-3’ 
5' STIM1 signal sequence - eYFP 
5’- CCTGCACCAGGGCCAGAGC ATGGTGAGCAAGGGCGAGGAGC-3’ 
3' STIM1 signal sequence - eYFP 
5’- GCTCCTCGCCCTTGCTCACCATGCTCTGGCCCTGGTGCAGG-3’ 
5' eYFP - STIM1 
5’- CTCGGCATGGACGAGCTGTACAAG GGCAGCGGCCTCAGCCA 
TAGTCACAGTGAGAAGGC 
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3' eYFP - STIM1 
5’-GCCTTCTCACTGTGACTATGGCTGAGGCCGCTGCCCTTGTAC 
AGCTCGTCCATGCCGAG 
3' STIM1 – STOP (For eYFP-STIM1) 
5’- CCTCTCAAAATCTTTAAGAAGCCTCTTAAGAAGTAGGCGGCCG 
CGTGACATGTCACGCGGCCGCCTACTTCTTAAGAGGCTTCTTAAAG 
ATTTTGAGAGG-3’ 
3' STIM1 (for eYFP-STIM1-mRFP) 
5’- CTTAAGAAGGCGGCCGCGTGACATGTCACGCGGCCGCCTTCTTA 
AGAGGCTTCTTAAAGATTTTGAGAGG-3’ 
AcGFP1-Orai1/CRACM1 5’ primer: 
5’-GCATTGAGATCTATGCATCCGGAGCCC-3’ 
AcGFP-Orai1/CRACM1 3’ primer: 
5’-TGTCTGGGTACCCTAGGCATAGTGGCTGC-3’ 
AcGFP-Orai1/CRACM1 5’ Flanking Primer (For Oria1.CRACM1 mutants) 
5’- GCCATCACCCACGGCATGGATGAGCTGTACAAGTCCGG-3’ 
AcGFP-Orai1/CRACM1 3’ Flanking Primer (For Oria1.CRACM1 mutants) 
5’- CCCCTAGGGTGGGCGAAGAACTCCAGCATGAGATCCC-3’ 
AcGFP-Orai/CRACM1 ∆D 5’ mutagenesis primer 
5’- CCCGCTTACAGAACCAGCTGAACCACAGAGGGAACCACCCCCTGAC-3’ 
AcGFP-Orai/CRACM1 ∆D 3’ mutagenesis primer 
5’- GTCAGGGGGTGGTTCCCTCTGTGGTTCAGCTGGTTCTGTAAGCGGG-3’ 
AcGFP-Orai/CRACM1 ∆E 5’ mutagenesis primer 
5’- GACAGTTCCAGCAGCTCAACCAGCTGGCGCAGTTTGCCCGC -3’ 
AcGFP-Orai/CRACM1 ∆E 3’ mutagenesis primer 
5’- GCGGGCAAACTGCGCCAGCTGGTTGAGCTGCTGGAACTGTC-3’ 
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B.1.2 Immunocytochemical staining of STIM1-HA, Tubulin-eGFP.  
 
Cells were plated for immunocytochemical staining of STIM-HA as for live 
cell imaging, and STIM1-HA and Tubulin-eGFP were transfected into cells. Cells 
were fixed with 4% paraformaldehyde plus 0.1% glutaraldehyde solution for 20 min at 
room temperature. Cells were washed in PBS, pH 7.4, containing 10 mg/mL BSA and 
0.01% NaN3, and labeled by incubation in this buffer for 1 h with Alexa594-labeled 
anti-HA mAb (1:200 dilution; Covance Research Products, Inc). 
  125 
 
Figure B.1: The integrated AcGFP fluorescence intensity for 18 cells used in 
Figure 2.6A to calculate FRET after thapsigargin stimulation. These data are 
presented to demonstrate that the error in the FRET observed in Figure 2.6A is smaller 
than variations in protein expression levels. 
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Figure B.2: α-Tubulin-eGFP (green), STIM1-HA with Alexa594-anti-HA (red), 
and overlay, demonstrating localization of epitope-tagged STIM1 with 
microtubules in fixed RBL cells. Experiment was performed as a control to evaluate 
the distribution of STIM1expressed without the fluorescent protein attached. 
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Figure B.3: Timecourse thapsigargin-stimulated formation of AcGFP-
Orai1/CRACM1 (green) and STIM1-mRFP (red) co-labeled plasma monitored 
by TIRF. Cells were prepared for TIRF microscopy in the same manner as described 
for confocal imaging. Cells were imaged on a Nikon TiE perfect focus inverted 
microscope with a Nikon CFI Plan Apo. TIRF 100X N.A. 1.49 objective and 
stimulated under the same conditions as described for confocal imaging. Scale bar 
indicates 10 µm. 
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Figure B.4: Intracellular calcium response monitored by indo-1 fluorescence from 
suspended RBL mast cells  A) Ca2+ response to 150 nM thapsigargin (indicated by 
bar) B) Ca2+ response to stimulation by 3 nM DNP-BSA in BSS. C) Ca2+ response to 
same antigen but in the absence of extracellular Ca2+. CaCl2 (1.8 mM) was restored as 
indicated by bar. D) Ca2+ response to antigen stimulation followed by addition of 6 
µM GdCl3 (upper trace) or to antigen stimulation after GdCl3 addition (lower trace). 
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Figure B.5: Equitorial Cross-sections A) Equatorial cross-sections of RBL mast cells 
expressing AcGFP-Orai1/CRACM1 (green) and STIM1-mRFP (red) under specified 
conditions of stimulation. Note negligible co-pixelation between STIM1-mRFP and 
AcGFP-Orai1/CRACM1 in unstimulated and antigen-stimulated cells in BSS (with 
CaCl2). This contrasts with thapsigargin-stimulated cells, antigen stimulated cells in 
the absence of extracellular Ca2+ (Ag, -Ca), and antigen stimulated cells in the 
presence of GdCl3 (Ag, +Gd
3+), for which extensive co-pixelation at the plasma 
membrane is seen. B) Cross-sectional images of RBL mast cells expressing AcGFP-
Orai1/CRACM1 that were stimulated or not as in A, then fixed and labeled with 
A555-CTB. Scale bars indicate 10 µm. 
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APPENDIX C 
SUPPLEMENT FOR CHAPTER 3 
 
Figure C.1: Population distributions of Ca2+ levels. Bars show the percentage of 
cells showing greater than 3x the Ca2+ of untransfected, prestimulation cells. Ca2+ 
levels (Fluo-4 fluorescence) were normalized to the average prestimulation Ca2+ level 
in untransfected cells for each experiment as in Figure 3. Distributions of Ca2+ levels 
in A) unstimulated cells, and B) cells after 10 min. in the presence of 150 nM 
thapsigargin. Cells scored in each sample were transfected with a pair of wild type or 
mutant STIM1 and Orai1. Each STIM1/Orai1 pair represents 20-60 cells, and error 
bars show SE. 
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APPENDIX D 
SUPPLEMENT FOR CHAPTER 4 
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Figure D.1: Inhibition of SOCE by cholesterol depletion and membrane 
depolarization. The indo-1 detected Ca2+ response to thapsigargin in cells treated 
with either 5 mM MβCD for 10 minutes (red) or no MβCD (blue) both in the presence 
(dotted line) or absence (solid line) of depolarizing K+ concentrations (140 mM). 
These results show that treatment of RBL-2H3 cells with MβCD does not desensitize 
their SOCE response to depolarization by high K+. 
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Figure D.2: Distribution of AcGFP-Orai1∆R before and after thapsigargin 
stimulation.  AcGFP-Orai1∆R (green) and STIM1-mRFP (red) before (top panel) and 
after (bottom panel) stimulation by thapsigargin. These results show that AcGFP-
Orai1∆R is similarly distributed to wild-type AcGFP-Orai1 both before and after 
stimulation of SOCE. 
